Functional	O
and	O
physical	O
interaction	O
of	O
protein-tyrosine	B-protein
kinases	I-protein
Fyn	I-protein
and	I-protein
Csk	I-protein
in	O
the	O
T-cell	O
signaling	O
system	O
.	O

The	O
Src-like	B-protein
protein-tyrosine	I-protein
kinase	I-protein
Fyn	B-protein
is	O
associated	O
with	O
T-cell	B-protein
antigen	I-protein
receptor	I-protein
.	O

Transient	O
expression	O
of	O
actively	O
mutated	O
Fyn	B-protein
,	O
having	O
Phe-528	O
instead	O
of	O
Tyr-528	O
or	O
Thr-338	O
instead	O
of	O
Ile-338	O
,	O
in	O
Jurkat	B-cell_type
T-cells	I-cell_type
stimulated	B-DNA
the	I-DNA
serum	I-DNA
response	I-DNA
element	I-DNA
(	O
SRE	B-DNA
)	O
,	O
12-O-tetradecanoyl-phorbol-13-acetate	B-DNA
response	I-DNA
element	I-DNA
,	O
cyclic	B-DNA
AMP	I-DNA
response	I-DNA
element	I-DNA
,	O
and	O
c-fos	B-DNA
promoter	I-DNA
.	O

The	O
stimulation	O
of	O
SRE	B-DNA
was	O
particularly	O
prominent	O
not	O
only	O
with	O
active	O
Fyn	B-protein
but	O
also	O
with	O
normal	B-protein
(	I-protein
wild-type	I-protein
)	I-protein
Fyn	I-protein
.	O

SRE	B-DNA
was	O
also	O
stimulated	O
by	O
both	O
normal	B-protein
and	I-protein
active	I-protein
Lck	I-protein
.	O

Furthermore	O
,	O
normal	B-protein
and	I-protein
active	I-protein
Fyn	I-protein
stimulated	O
transcription	O
from	O
the	O
IL-2	B-DNA
gene	I-DNA
promoter	I-DNA
when	O
transfected	O
cells	O
were	O
stimulated	O
by	O
concanavalin	B-protein
A	I-protein
plus	O
12-O-tetradecanoylphorbol-13-acetate	O
.	O

Under	O
the	O
same	O
conditions	O
,	O
Lck	B-protein
did	O
not	O
stimulate	O
IL-2	B-DNA
promoter	I-DNA
unless	O
it	O
was	O
activated	O
by	O
mutation	O
.	O

Interestingly	O
,	O
a	O
mutant	B-protein
Fyn	I-protein
,	O
which	O
has	O
deletions	O
within	O
the	O
SH2	B-protein
region	I-protein
and	O
so	O
is	O
able	O
to	O
transform	O
chicken	B-cell_type
embryo	I-cell_type
fibroblasts	I-cell_type
,	O
did	O
not	O
stimulate	O
either	O
the	O
c-fos	B-DNA
or	I-DNA
IL-2	I-DNA
promoter	I-DNA
,	O
suggesting	O
the	O
importance	O
of	O
this	O
region	O
in	O
T-cell	B-cell_type
signaling	O
.	O

Csk	B-protein
,	O
which	O
phosphorylates	O
tyrosine	O
residues	O
in	O
the	O
negative	O
regulatory	O
sites	O
of	O
Src	B-protein
family	I-protein
kinases	I-protein
,	O
down-regulated	O
Fyn-	O
and	O
Lck-mediated	O
stimulation	O
of	O
the	O
serum	B-DNA
response	I-DNA
element	I-DNA
and	O
Fyn-mediated	O
enhancement	O
of	O
IL-2	B-DNA
promoter	I-DNA
activity	O
.	O

These	O
data	O
suggest	O
that	O
Fyn	B-protein
and	O
Lck	B-protein
,	O
whose	O
activities	O
are	O
regulated	O
by	O
Csk	B-protein
,	O
are	O
involved	O
in	O
different	O
phases	O
of	O
T-cell	B-cell_type
activation	O
.	O

Tax	NULL
Journat	NULL
or	NULL
Broocicat	NULL
.	NULL

©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

268	NULL
,	NULL
No	NULL
.	NULL

36	NULL
,	NULL
Issue	NULL
of	NULL
December	NULL
25	NULL
,	NULL
pp	NULL
.	NULL

27413-27419	NULL
,	NULL
1993	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Functional	NULL
and	NULL
Physical	NULL
Interaction	NULL
of	NULL
Protein-tyrosine	NULL
Kinases	NULL
Fyn	NULL
and	NULL
Csk	NULL
in	NULL
the	NULL
T-cell	NULL
Signaling	NULL
System*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
July	NULL
23	NULL
,	NULL
1993	NULL
)	NULL
Masakazu	NULL
Takeuchi	NULL
,	NULL
Satomi	NULL
Kuramochi	NULL
,	NULL
Noemi	NULL
Fusaki	NULL
,	NULL
Shigeyuki	NULL
Nadat	NULL
#	NULL
,	NULL
Junko	NULL
Kawamura-Tsuzuku	NULL
,	NULL
Satoru	NULL
Matsuda	NULL
,	NULL
Kentaro	NULL
Semba	NULL
,	NULL
Kumao	NULL
Masato	NULL
Okadat	NULL
,	NULL
and	NULL
Tadashi	NULL
Yamamoto1	NULL
From	NULL
the	NULL
Institute	NULL
of	NULL
Medical	NULL
Science	NULL
,	NULL
The	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
4-6-1	NULL
Shirokanedai	NULL
,	NULL
Minato-ku	NULL
,	NULL
Tokyo	NULL
108	NULL
,	NULL
Japan	NULL
and	NULL
the	NULL
{	NULL
Institute	NULL
for	NULL
Protein	NULL
Research	NULL
and	NULL
§Research	NULL
Institute	NULL
for	NULL
Microbial	NULL
Diseases	NULL
,	NULL
Osaka	NULL
University	NULL
,	NULL
Yamadaoka	NULL
,	NULL
Suita	NULL
,	NULL
Osaka	NULL
565	NULL
,	NULL
Japan	NULL
The	NULL
Src-like	NULL
protein-tyrosine	NULL
kinase	NULL
Fyn	NULL
is	NULL
associated	NULL
with	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
actively	NULL
mutated	NULL
Fyn	NULL
,	NULL
having	NULL
Phe-528	NULL
instead	NULL
of	NULL
Tyr-528	NULL
or	NULL
Thr-338	NULL
instead	NULL
of	NULL
Ie-338	NULL
,	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
stimulated	NULL
the	NULL
serum	NULL
response	NULL
element	NULL
(	NULL
SRE	NULL
)	NULL
,	NULL
12-O-tetradecanoyl-phorbol-18-acetate	NULL
response	NULL
element	NULL
,	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
,	NULL
and	NULL
c-fos	NULL
promoter	NULL
.	NULL

The	NULL
stimulation	NULL
of	NULL
SRE	NULL
was	NULL
particularly	NULL
prominent	NULL
not	NULL
only	NULL
with	NULL
active	NULL
Fyn	NULL
but	NULL
also	NULL
with	NULL
normal	NULL
(	NULL
wild-type	NULL
)	NULL
Fyn	NULL
.	NULL

SRE	NULL
was	NULL
also	NULL
stimulated	NULL
by	NULL
both	NULL
normal	NULL
and	NULL
active	NULL
Lock	NULL
.	NULL

Furthermore	NULL
,	NULL
normal	NULL
and	NULL
active	NULL
Fyn	NULL
stimulated	NULL
transcription	NULL
from	NULL
the	NULL
IL-2	NULL
gene	NULL
promoter	NULL
when	NULL
transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
concanavalin	NULL
A	NULL
plus	NULL
12-O-tetradecanoy	NULL
}	NULL
-phorbol-13-acetate	NULL
.	NULL

Under	NULL
the	NULL
same	NULL
conditions	NULL
,	NULL
Lok	NULL
did	NULL
not	NULL
stimulate	NULL
IL-2	NULL
promoter	NULL
unless	NULL
it	NULL
was	NULL
activated	NULL
by	NULL
mutation	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
mutant	NULL
Fyn	NULL
,	NULL
which	NULL
has	NULL
deletions	NULL
within	NULL
the	NULL
SH2	NULL
region	NULL
and	NULL
so	NULL
is	NULL
able	NULL
to	NULL
transform	NULL
chicken	NULL
embryo	NULL
fibroblasts	NULL
,	NULL
did	NULL
not	NULL
stimulate	NULL
either	NULL
the	NULL
c-fos	NULL
or	NULL
IL-2	NULL
promoter	NULL
,	NULL
suggesting	NULL
the	NULL
importance	NULL
of	NULL
this	NULL
region	NULL
in	NULL
T-cell	NULL
signaling	NULL
.	NULL

Csk	NULL
,	NULL
which	NULL
phosphorylates	NULL
tyrosine	NULL
residues	NULL
in	NULL
the	NULL
negative	NULL
regulatory	NULL
sites	NULL
of	NULL
Sre	NULL
family	NULL
kinases	NULL
,	NULL
down-regulated	NULL
Fyn-	NULL
and	NULL
Lek-mediated	NULL
stimulation	NULL
of	NULL
the	NULL
serum	NULL
response	NULL
element	NULL
and	NULL
Fyn-mediated	NULL
enhancement	NULL
of	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
Fyn	NULL
and	NULL
Lock	NULL
,	NULL
whose	NULL
activities	NULL
are	NULL
regulated	NULL
by	NULL
Csk	NULL
,	NULL
are	NULL
involved	NULL
in	NULL
different	NULL
phases	NULL
of	NULL
T-cell	NULL
activation	NULL
.	NULL

The	NULL
Sre-like	NULL
kinases	NULL
are	NULL
generally	NULL
associated	NULL
with	NULL
the	NULL
internal	NULL
portion	NULL
of	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
are	NULL
suggested	NULL
to	NULL
play	NULL
crucial	NULL
roles	NULL
in	NULL
surface	NULL
receptor-mediated	NULL
signaling	NULL
(	NULL
1-8	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
enzymatic	NULL
activities	NULL
of	NULL
Src-like	NULL
kinases	NULL
are	NULL
regulated	NULL
by	NULL
phosphorylation	NULL
and	NULL
dephosphorylation	NULL
of	NULL
tyrosine	NULL
residues	NULL
in	NULL
their	NULL
carboxy-terminal	NULL
regions	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
identify	NULL
the	NULL
enzymes	NULL
responsible	NULL
for	NULL
these	NULL
activities	NULL
.	NULL

Recently	NULL
an	NULL
enzyme	NULL
that	NULL
phosphorylates	NULL
a	NULL
tyrosine	NULL
residue	NULL
close	NULL
to	NULL
the	NULL
car-boxyl	NULL
terminus	NULL
of	NULL
c-Src	NULL
,	NULL
tyrosine	NULL
527	NULL
,	NULL
was	NULL
purified	NULL
from	NULL
the	NULL
membrane	NULL
fraction	NULL
of	NULL
neonatal	NULL
rat	NULL
brain	NULL
and	NULL
named	NULL
Csk	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Csk	NULL
can	NULL
also	NULL
phosphorylate	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Src	NULL
family	NULL
such	NULL
as	NULL
Fyn	NULL
and	NULL
Lyn	NULL
at	NULL
the	NULL
conserved	NULL
tyrosine	NULL
residue	NULL
within	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
.	NULL

Consequently	NULL
,	NULL
Csk	NULL
down-regu-lates	NULL
the	NULL
kinase	NULL
activities	NULL
of	NULL
Src	NULL
,	NULL
Fyn	NULL
,	NULL
and	NULL
Lyn	NULL
in	NULL
vitro	NULL
(	NULL
10	NULL
)	NULL
and	NULL
suppresses	NULL
cell	NULL
transformation	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
c-Sre	NULL
and	NULL
Crk	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Recent	NULL
evidence	NULL
also	NULL
shows	NULL
that	NULL
Csk	NULL
is	NULL
able	NULL
to	NULL
rescue	NULL
the	NULL
c-Src-induced	NULL
lethal	NULL
phenotype	NULL
of	NULL
Saccharomyces	NULL
pombe	NULL
,	NULL
presumably	NULL
by	NULL
regulating	NULL
kinase	NULL
activity	NULL
of	NULL
the	NULL
c-Sre	NULL
protein	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Csk	NULL
is	NULL
expressed	NULL
in	NULL
lymphoid	NULL
tissues	NULL
and	NULL
in	NULL
neonatal	NULL
brain	NULL
(	NULL
10	NULL
)	NULL
,	NULL
which	NULL
is	NULL
rich	NULL
in	NULL
Sre	NULL
family	NULL
kinases	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
13	NULL
)	NULL
.	NULL

There-fore	NULL
,	NULL
Csk	NULL
may	NULL
negatively	NULL
regulate	NULL
the	NULL
functions	NULL
of	NULL
these	NULL
Src-like	NULL
kinases	NULL
in	NULL
lymphoid	NULL
and	NULL
neural	NULL
cells	NULL
.	NULL

The	NULL
response	NULL
of	NULL
T-cells	NULL
to	NULL
antigen	NULL
bound	NULL
to	NULL
the	NULL
antigen	NULL
receptor	NULL
(	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
'	NULL
)	NULL
-major	NULL
histocompatibility	NULL
complex	NULL
consists	NULL
of	NULL
a	NULL
series	NULL
of	NULL
cellular	NULL
events	NULL
that	NULL
result	NULL
in	NULL
expression	NULL
of	NULL
a	NULL
number	NULL
of	NULL
genes	NULL
including	NULL
the	NULL
c-fos	NULL
and	NULL
IL-2	NULL
genes	NULL
(	NULL
14	NULL
)	NULL
.	NULL

There	NULL
are	NULL
reports	NULL
that	NULL
activation	NULL
of	NULL
protein-tyrosine	NULL
kinases	NULL
following	NULL
TCR	NULL
stimulation	NULL
is	NULL
required	NULL
and	NULL
precede	NULL
these	NULL
intracellular	NULL
events	NULL
(	NULL
15	NULL
)	NULL
.	NULL

In	NULL
most	NULL
cases	NULL
TCR	NULL
consists	NULL
of	NULL
an	NULL
aB	NULL
heterodimer	NULL
and	NULL
CD3	NULL
subunits	NULL
that	NULL
are	NULL
y	NULL
,	NULL
8	NULL
,	NULL
e	NULL
,	NULL
and	NULL
{	NULL
(	NULL
and/or	NULL
1	NULL
)	NULL
chains	NULL
.	NULL

However	NULL
,	NULL
none	NULL
of	NULL
these	NULL
molecules	NULL
possesses	NULL
intrinsic	NULL
protein-tyrosine	NULL
kinase	NULL
activity	NULL
.	NULL

Recent	NULL
evidence	NULL
suggests	NULL
that	NULL
Src-like	NULL
protein-tyrosine	NULL
kinases	NULL
couple	NULL
the	NULL
TCR	NULL
for	NULL
the	NULL
signaling	NULL
events	NULL
(	NULL
15	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
Fyn	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
in	NULL
mature	NULL
T-cells	NULL
,	NULL
physically	NULL
associates	NULL
with	NULL
the	NULL
CD3	NULL
complex	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
Fyn	NULL
in	NULL
TCR-mediated	NULL
signal	NULL
transduction	NULL
is	NULL
further	NULL
suggested	NULL
by	NULL
the	NULL
following	NULL
studies	NULL
.	NULL

By	NULL
use	NULL
of	NULL
a	NULL
transgenic	NULL
mice	NULL
system	NULL
,	NULL
thymocytes	NULL
expressing	NULL
a	NULL
high	NULL
level	NULL
of	NULL
the	NULL
fyn	NULL
transgene	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
hyperstimulatable	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Studies	NULL
using	NULL
fyn~	NULL
mice	NULL
revealed	NULL
that	NULL
TCR-mediated	NULL
signaling	NULL
was	NULL
defective	NULL
in	NULL
mature	NULL
single	NULL
positive	NULL
(	NULL
CD4*CDS8~	NULL
or	NULL
CD4-CD8+*	NULL
)	NULL
thymocytes	NULL
,	NULL
although	NULL
the	NULL
signaling	NULL
was	NULL
still	NULL
present	NULL
in	NULL
immature	NULL
thymocytes	NULL
and	NULL
peripheral	NULL
T-cells	NULL
(	NULL
18	NULL
,	NULL
20	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
data	NULL
suggest	NULL
that	NULL
fyn	NULL
is	NULL
critically	NULL
important	NULL
in	NULL
TCR-mediated	NULL
signaling	NULL
,	NULL
at	NULL
least	NULL
in	NULL
a	NULL
developmentally	NULL
restricted	NULL
subpopulation	NULL
of	NULL
thymocytes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
unpublished	NULL
data	NULL
suggest	NULL
that	NULL
IL-2	NULL
production	NULL
is	NULL
elevated	NULL
in	NULL
T-cell	NULL
hybridomas	NULL
expressing	NULL
high	NULL
levels	NULL
of	NULL
wild-type	NULL
and	NULL
actively	NULL
mutated	NULL
Fyns	NULL
upon	NULL
mitogenic	NULL
stimulation	NULL
.	NULL
``	NULL

To	NULL
obtain	NULL
further	NULL
details	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
T-cell	NULL
signaling	NULL
,	NULL
we	NULL
have	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
Fyn	NULL
and	NULL
Csk	NULL
expression	NULL
on	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
IL-2	NULL
promoters	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
Culture-Human	NULL
Jurkat	NULL
T-cells	NULL
,	NULL
donated	NULL
from	NULL
T.	NULL
Taniguchi	NULL
(	NULL
Osaka	NULL
University	NULL
,	NULL
Japan	NULL
)	NULL
and	NULL
Class	NULL
II-restricted	NULL
mouse	NULL
helper	NULL
T-cell	NULL
hybridoma	NULL
HBC21.7.31	NULL
and	NULL
its	NULL
derivatives®	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

The	NULL
monkey	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant-in-aid	NULL
for	NULL
special	NULL
project	NULL
re-search	NULL
,	NULL
cancer-bioscience	NULL
,	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
,	NULL
and	NULL
Culture	NULL
of	NULL
Japan	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

T	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL
'	NULL

The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TCR	NULL
,	NULL
T-cell	NULL
receptor	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
ConA	NULL
,	NULL
concanavalin	NULL
A	NULL
;	NULL
TPA	NULL
,	NULL
12-O-tetradec-anoylphorbol-13-acetate	NULL
;	NULL
SRE	NULL
,	NULL
serum	NULL
response	NULL
element	NULL
;	NULL
TRE	NULL
,	NULL
TPA	NULL
response	NULL
element	NULL
;	NULL
CRE	NULL
,	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
;	NULL
SH2	NULL
,	NULL
Src	NULL
homology-2	NULL
.	NULL

*	NULL
N.	NULL
Fusaki	NULL
,	NULL
S.	NULL
Matsuda	NULL
,	NULL
G.	NULL
Suzuki	NULL
,	NULL
K.	NULL
Semba	NULL
,	NULL
T.	NULL
Katagiri	NULL
,	NULL
and	NULL
T.	NULL
Yamamoto	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

27413	NULL
27414	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Schematic	NULL
representations	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
fyn	NULL
gene	NULL
products	NULL
.	NULL

A	NULL
,	NULL
the	NULL
structures	NULL
of	NULL
B-Fyn	NULL
and	NULL
its	NULL
derivatives	NULL
(	NULL
£-14	NULL
and	NULL
t-1	NULL
)	NULL
are	NULL
according	NULL
to	NULL
Semba	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
,	NULL
and	NULL
that	NULL
of	NULL
T-F'yn	NULL
was	NULL
obtained	NULL
by	NULL
determining	NULL
the	NULL
nucleotide	NULL
Regulation	NULL
of	NULL
T-cell	NULL
Signaling	NULL
by	NULL
Protein-tyrosine	NULL
Kinases	NULL
Transforming	NULL
Kinase	NULL
sequence	NULL
of	NULL
exon	NULL
7B	NULL
(	NULL
22	NULL
)	NULL
of	NULL
the	NULL
human	NULL
fyr	NULL
gene	NULL
.	NULL

The	NULL
transforming	NULL
ability	NULL
of	NULL
each	NULL
Fyn	NULL
is	NULL
as	NULL
determined	NULL
on	NULL
chick	NULL
embryo	NULL
fi-	NULL
broblasts	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Relative	NULL
kinase	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
the	NULL
level	NULL
of	NULL
in	NULL
vitro	NULL
autophosphorylation	NULL
of	NULL
each	NULL
Fyn	NULL
immunoprecipitated	NULL
from	NULL
CV-1	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
transfected	NULL
with	NULL
the	NULL
expression	NULL
plasmid	NULL
containing	NULL
corresponding	NULL
fyn	NULL
cDNA	NULL
.	NULL

Tyrosine	NULL
to	NULL
phenylalanine	NULL
muta-	NULL
tion	NULL
at	NULL
amino	NULL
acid	NULL
positions	NULL
528	NULL
and	NULL
531	NULL
is	NULL
indicated	NULL
as	NULL
Y528F	NULL
and	NULL
Y531F	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
isoleucine	NULL
to	NULL
threonine	NULL
muta-	NULL
Activity	NULL
|__	NULL
Activity	NULL
T-fyn	NULL
-	NULL
(	NULL
Thymustype	NULL
)	NULL
|__	NULL
NT	NULL
+	NULL
Em	NULL
TfyoF	NULL
(	NULL
¥528F	NULL
)	NULL
NT	NULL
+++	NULL
B-fyn	NULL
_	NULL
(	NULL
Brain	NULL
type	NULL
)	NULL
-_	NULL
+	NULL
E	NULL
,	NULL
B-fynF	NULL
(	NULL
Y531F	NULL
)	NULL
NT	NULL
+++	NULL
a	NULL
£14	NULL
_	NULL
(	NULL
3387	NULL
)	NULL
+	NULL
++++	NULL
+1	NULL
__	NULL
dd	NULL
.	NULL
)	NULL

+	NULL
4	NULL
+	NULL
tion	NULL
at	NULL
position	NULL
338	NULL
as	NULL
1338T	NULL
.	NULL

B	NULL
,	NULL
the	NULL
amino	NULL
acid	NULL
sequences	NULL
encoded	NULL
by	NULL
exons	NULL
7A	NULL
and	NULL
7B	NULL
of	NULL
human	NULL
B-fyr	NULL
and	NULL
Tfyn	NULL
,	NULL
respectively	NULL
,	NULL
are	NULL
compared	NULL
.	NULL

Only	NULL
amino	NULL
acid	NULL
residues	NULL
of	NULL
T-Fyn	NULL
that	NULL
differ	NULL
from	NULL
the	NULL
corresponding	NULL
residues	NULL
of	NULL
B-Fyn	NULL
are	NULL
indi-cated	NULL
.	NULL

Dots	NULL
show	NULL
the	NULL
identical	NULL
residues	NULL
B	NULL
between	NULL
the	NULL
two	NULL
Fyns	NULL
.	NULL

Dashes	NULL
show	NULL
the	NULL
residues	NULL
missing	NULL
in	NULL
T-Fyn	NULL
.	NULL

kidney	NULL
fibroblast	NULL
cell	NULL
line	NULL
CV-1	NULL
was	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
calf	NULL
serum	NULL
.	NULL

Construction	NULL
of	NULL
Expression	NULL
Plasmids-The	NULL
expression	NULL
vector	NULL
pME18SM	NULL
containing	NULL
SRa	NULL
promoter	NULL
(	NULL
20	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
K.	NULL
Maruyama	NULL
(	NULL
Tokyo	NULL
University	NULL
)	NULL
.	NULL

The	NULL
complementary	NULL
DNAs	NULL
encoding	NULL
T-Fyn	NULL
were	NULL
obtained	NULL
by	NULL
the	NULL
following	NULL
modifications	NULL
of	NULL
pSRD-FN	NULL
(	NULL
21	NULL
)	NULL
,	NULL
which	NULL
contained	NULL
1.8-kilobase	NULL
pair	NULL
B-fyn	NULL
cDNA	NULL
.	NULL

A	NULL
sequence	NULL
corresponding	NULL
to	NULL
exon	NULL
7A	NULL
(	NULL
22	NULL
)	NULL
specific	NULL
to	NULL
brain	NULL
type	NULL
Fyn	NULL
was	NULL
replaced	NULL
by	NULL
that	NULL
corresponding	NULL
to	NULL
exon	NULL
7B	NULL
(	NULL
22	NULL
)	NULL
,	NULL
which	NULL
was	NULL
synthesized	NULL
by	NULL
reverse	NULL
transcription	NULL
of	NULL
mRNA	NULL
from	NULL
Jurkat	NULL
T-cells	NULL
followed	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
23	NULL
)	NULL
,	NULL
The	NULL
primers	NULL
used	NULL
for	NULL
polymerase	NULL
chain	NULL
reaction	NULL
were	NULL
5-CCACCCGGGC-CAAGCTTGAAACACTTC-3	NULL
'	NULL
and	NULL
5-GCCTGGTTTAAGAAGCTTTAT	NULL
GGCTAC-3	NULL
'	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
sense	NULL
sequence	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
exon	NULL
6	NULL
and	NULL
the	NULL
antisense	NULL
sequence	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
exon	NULL
8	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
primers	NULL
contained	NULL
HindIII	NULL
sites	NULL
,	NULL
which	NULL
were	NULL
created	NULL
by	NULL
introducing	NULL
point	NULL
mutations	NULL
(	NULL
shown	NULL
above	NULL
in	NULL
boldface	NULL
letters	NULL
)	NULL
in	NULL
the	NULL
authentic	NULL
sequence	NULL
of	NULL
fyn	NULL
cDNA	NULL
.	NULL

The	NULL
boundaries	NULL
of	NULL
the	NULL
exons	NULL
were	NULL
deduced	NULL
from	NULL
those	NULL
of	NULL
the	NULL
c-src	NULL
gene	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
amplified	NULL
DNA	NULL
fragments	NULL
for	NULL
exon	NULL
7	NULL
were	NULL
cleaved	NULL
by	NULL
Hindlll	NULL
and	NULL
cloned	NULL
in	NULL
pUC119	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
exon	NULL
7B	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
standard	NULL
dideoxy	NULL
chain	NULL
termination	NULL
method	NULL
.	NULL

The	NULL
deduced	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
exon	NULL
7B	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
exon	NULL
7A	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
T-fyn	NULL
cDNA	NULL
as	NULL
well	NULL
as	NULL
B-fyn	NULL
,	NULL
t-lfyn	NULL
,	NULL
and	NULL
f-14fyn	NULL
cDNAs	NULL
were	NULL
excised	NULL
from	NULL
pSRD	NULL
vector	NULL
(	NULL
21	NULL
)	NULL
and	NULL
recloned	NULL
into	NULL
pME18SM	NULL
at	NULL
the	NULL
Miul	NULL
site	NULL
.	NULL

The	NULL
DNA	NULL
fragments	NULL
of	NULL
the	NULL
Ick	NULL
cDNA	NULL
(	NULL
25	NULL
)	NULL
obtained	NULL
from	NULL
T.	NULL
Shimotohno	NULL
(	NULL
National	NULL
Cancer	NULL
Center	NULL
,	NULL
Tokyo	NULL
)	NULL
,	NULL
the	NULL
lyn	NULL
cDNA	NULL
(	NULL
13	NULL
)	NULL
,	NULL
and	NULL
the	NULL
csk	NULL
cDNA	NULL
(	NULL
26	NULL
)	NULL
were	NULL
converted	NULL
to	NULL
the	NULL
Miul	NULL
fragments	NULL
by	NULL
attaching	NULL
the	NULL
Miul	NULL
linker	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
which	NULL
were	NULL
then	NULL
recloned	NULL
into	NULL
the	NULL
Miul	NULL
site	NULL
of	NULL
pME18SM	NULL
.	NULL

Tyrosine	NULL
to	NULL
phenylalanine	NULL
mutation	NULL
at	NULL
amino	NULL
acid	NULL
positions	NULL
505	NULL
of	NULL
Lek	NULL
,	NULL
508	NULL
of	NULL
Lyn	NULL
,	NULL
and	NULL
528	NULL
and	NULL
531	NULL
of	NULL
T-FynF	NULL
and	NULL
B-FynF	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
introduced	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Kunkel	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
modified	NULL
sequences	NULL
were	NULL
confirmed	NULL
by	NULL
nucleotide	NULL
sequencing	NULL
.	NULL

The	NULL
reporter	NULL
plasmids	NULL
containing	NULL
bacterial	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
,	NULL
TRECAT	NULL
,	NULL
SRECAT	NULL
,	NULL
CRECAT	NULL
,	NULL
and	NULL
c-fos	NULL
CAT	NULL
(	NULL
28	NULL
)	NULL
were	NULL
from	NULL
K.	NULL
Kaibuchi	NULL
(	NULL
Kobe	NULL
University	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

The	NULL
IL-2	NULL
CAT	NULL
plasmid	NULL
(	NULL
29	NULL
)	NULL
was	NULL
from	NULL
T.	NULL
Taniguchi	NULL
(	NULL
Osaka	NULL
University	NULL
)	NULL
.	NULL

pBact-Bgal	NULL
plasmid	NULL
,	NULL
in	NULL
which	NULL
the	NULL
-actin	NULL
promoter	NULL
was	NULL
placed	NULL
upstream	NULL
of	NULL
the	NULL
B-galactosidase	NULL
gene	NULL
,	NULL
was	NULL
from	NULL
S.	NULL
Ishii	NULL
(	NULL
RIKEN	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Transfection	NULL
Assay	NULL
for	NULL
CAT-Eiffector	NULL
plasmid	NULL
DNAs	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T-cells	NULL
together	NULL
with	NULL
the	NULL
reporter	NULL
plasmid	NULL
and	NULL
pBact-Bgal	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
as	NULL
described	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
ConA	NULL
(	NULL
30	NULL
ug/ml	NULL
)	NULL
and	NULL
TPA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
8	NULL
h	NULL
before	NULL
cell	NULL
harvest	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
harvested	NULL
at	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
lysed	NULL
as	NULL
described	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
lysates	NULL
(	NULL
80	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
were	NULL
forwarded	NULL
to	NULL
CAT	NULL
assay	NULL
as	NULL
described	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

CAT	NULL
activities	NULL
of	NULL
the	NULL
reaction	NULL
products	NULL
were	NULL
quantitated	NULL
with	NULL
a	NULL
Fujix	NULL
Bio-Image	NULL
Analyzer	NULL
BAS	NULL
2000	NULL
(	NULL
Fuji	NULL
Film	NULL
,	NULL
Tokyo	NULL
)	NULL
.	NULL

The	NULL
transfection	NULL
efficiency	NULL
was	NULL
monitored	NULL
by	NULL
measuring	NULL
the	NULL
-galactosidase	NULL
activity	NULL
of	NULL
the	NULL
cell	NULL
lysates	NULL
.	NULL

Immunoblotting-Cells	NULL
were	NULL
washed	NULL
with	NULL
serum-free	NULL
medium	NULL
and	NULL
lysed	NULL
with	NULL
ice-cold	NULL
RIPA	NULL
buffer	NULL
(	NULL
20	NULL
mx	NULL
Tris-HCH	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
Brain-type	NULL
:	NULL
_	NULL
RAAGLCCRLYYPCHKGMPRLTDLSYYTKDVWEIPRESLQLIKRLGNGQFGEYWM	NULL
“	NULL
mm	NULL
K-D+	NULL
«	NULL
++F	NULL
N	NULL
«	NULL
T	NULL
»	NULL
I	NULL
ASS	NULL
CT	NULL
‘	NULL
QT.-	NULL
.	NULL

*	NULL
GLA**+A	NULL
+	NULL
«	NULL
VArRC-E	NULL
>	NULL
Ke+	NULL
QCeAr	NULL
++	NULL
L	NULL
1	NULL
ma	NULL
EDTA	NULL
,	NULL
0.5	NULL
mm	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
20	NULL
mx	NULL
NaF	NULL
,	NULL
1	NULL
mx	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
50	NULL
ng/m	NULL
!	NULL

aprotinin	NULL
)	NULL
containing	NULL
1	NULL
%	NULL
SDS	NULL
and	NULL
1	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
.	NULL

Proteins	NULL
(	NULL
50	NULL
ug	NULL
)	NULL
in	NULL
the	NULL
lysates	NULL
were	NULL
separated	NULL
by	NULL
7.5	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
blotted	NULL
onto	NULL
Immobilon-P	NULL
filters	NULL
(	NULL
Millipore	NULL
)	NULL
,	NULL
which	NULL
were	NULL
subsequently	NULL
probed	NULL
with	NULL
anti-Fyn	NULL
antibody	NULL
(	NULL
32	NULL
)	NULL
or	NULL
anti-Csk	NULL
antibody	NULL
as	NULL
described	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Co-immunoprecipitation	NULL
and	NULL
Kinase	NULL
Assay-All	NULL
procedures	NULL
were	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
7	NULL
)	NULL
with	NULL
slight	NULL
modification	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
with	NULL
TNE	NULL
buffer	NULL
(	NULL
50	NULL
mm	NULL
Tris	NULL
:	NULL
HCl	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
20	NULL
mx	NULL
EDTA	NULL
,	NULL
0.2	NULL
my	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
and	NULL
10	NULL
pg/ml	NULL
]	NULL
aprotinin	NULL
}	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
incubated	NULL
with	NULL
anti-Fyn	NULL
or	NULL
anti-Csk	NULL
antibodies	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
1.5	NULL
b	NULL
,	NULL
and	NULL
the	NULL
immune	NULL
complexes	NULL
were	NULL
precipitated	NULL
with	NULL
protein-G	NULL
Sepharose	NULL
(	NULL
Pharmacia	NULL
LKB	NULL
Biotechnology	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
resuspended	NULL
in	NULL
kinase	NULL
buffer	NULL
(	NULL
20	NULL
my	NULL
Hepes	NULL
NaOH	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
10	NULL
mx	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
1	NULL
um	NULL
ATP	NULL
)	NULL
with	NULL
37	NULL
kBq	NULL
of	NULL
[	NULL
y-*°P	NULL
]	NULL
JATP	NULL
at	NULL
25	NULL
°C	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
reaction	NULL
products	NULL
were	NULL
analyzed	NULL
on	NULL
8.5	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

For	NULL
co-immunoprecipitation	NULL
assay	NULL
the	NULL
phosphopro-teins	NULL
in	NULL
the	NULL
anti-Csk	NULL
immunoprecipitates	NULL
were	NULL
reextracted	NULL
with	NULL
solu-bilizing	NULL
buffer	NULL
(	NULL
10	NULL
my	NULL
Tris-	NULL
HCI	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
1	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
,	NULL
10	NULL
pg/ml	NULL
aprotinin	NULL
)	NULL
and	NULL
reimmunoprecipitated	NULL
with	NULL
anti-Fyn	NULL
antibody	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
separated	NULL
by	NULL
8.5	NULL
%	NULL
SDS-polyacrylamide	NULL
ge	NULL
!	NULL

electrophoresis	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

RESULTS	NULL
Stimulation	NULL
of	NULL
c-fos	NULL
Promoter	NULL
and	NULL
IL-2	NULL
Promoter	NULL
Activities	NULL
by	NULL
Kinase-active	NULL
Fyn-The	NULL
cDNA	NULL
of	NULL
active	NULL
T-fyn	NULL
(	NULL
T-FynF	NULL
,	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
that	NULL
encodes	NULL
thymus-type	NULL
Fyn	NULL
(	NULL
22	NULL
)	NULL
with	NULL
Phe-528	NULL
instead	NULL
of	NULL
Tyr-528	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
expression	NULL
plasmid	NULL
pME18SM	NULL
containing	NULL
a	NULL
chimeric	NULL
promoter	NULL
(	NULL
SRe	NULL
)	NULL
of	NULL
the	NULL
SV40	NULL
and	NULL
human	NULL
T	NULL
lymphotropic	NULL
virus-l	NULL
promoters	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Reporter	NULL
plasmid	NULL
c-fos	NULL
CAT	NULL
(	NULL
28	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
the	NULL
T-fynF	NULL
expression	NULL
plasmids	NULL
into	NULL
Jurkat	NULL
T-cells	NULL
,	NULL
which	NULL
were	NULL
chosen	NULL
because	NULL
of	NULL
the	NULL
similarity	NULL
of	NULL
their	NULL
response	NULL
to	NULL
TCR	NULL
stimulation	NULL
to	NULL
that	NULL
of	NULL
normal	NULL
resting	NULL
T-cells	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
T-fynF	NULL
significantly	NULL
increased	NULL
the	NULL
c-fos	NULL
promoter	NULL
activity	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
c-fos	NULL
promoter	NULL
contains	NULL
the	NULL
serum	NULL
response	NULL
element	NULL
(	NULL
SRE	NULL
)	NULL
,	NULL
the	NULL
TPA	NULL
response	NULL
element	NULL
(	NULL
TRE	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
(	NULL
35	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
which	NULL
element	NULL
was	NULL
responsible	NULL
for	NULL
the	NULL
T-fynF-mediated	NULL
stimulation	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

For	NULL
this	NULL
,	NULL
we	NULL
transfected	NULL
the	NULL
T-fynF	NULL
construct	NULL
into	NULL
Jurkat	NULL
cells	NULL
together	NULL
with	NULL
the	NULL
SRECAT	NULL
,	NULL
TRECAT	NULL
,	NULL
or	NULL
CRECAT	NULL
reporter	NULL
plasmid	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Results	NULL
showed	NULL
that	NULL
T-FynF	NULL
stimulated	NULL
these	NULL
elements	NULL
and	NULL
the	NULL
stimulation	NULL
of	NULL
SRE	NULL
was	NULL
more	NULL
than	NULL
those	NULL
of	NULL
TRE	NULL
and	NULL
CRE	NULL
(	NULL
Fig	NULL
.	NULL

Regulation	NULL
of	NULL
T-cell	NULL
Signaling	NULL
by	NULL
Protein-tyrosine	NULL
Kinases	NULL
27415	NULL
Tasie	NULL
I	NULL
Stimulation	NULL
of	NULL
fos	NULL
and	NULL
IL-2	NULL
promoters	NULL
by	NULL
Fyn	NULL
Various	NULL
Fyn	NULL
cDNA	NULL
constructs	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
in	NULL
pME18SM	NULL
vector	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T-cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
)	NULL
together	NULL
with	NULL
reporter	NULL
plasmids	NULL
,	NULL
c-fos	NULL
CAT	NULL
(	NULL
Fos	NULL
)	NULL
,	NULL
SRECAT	NULL
(	NULL
SRE	NULL
)	NULL
,	NULL
TRECAT	NULL
(	NULL
TRE	NULL
)	NULL
,	NULL
CRECAT	NULL
(	NULL
CRE	NULL
)	NULL
,	NULL
or	NULL
IL-2	NULL
CAT	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
as	NULL
described	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

The	NULL
lysates	NULL
(	NULL
80	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
of	NULL
the	NULL
transfectants	NULL
were	NULL
subjected	NULL
to	NULL
CAT	NULL
assay	NULL
as	NULL
described	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

The	NULL
transfectants	NULL
of	NULL
IL-2CAT	NULL
were	NULL
treated	NULL
with	NULL
ConA	NULL
(	NULL
30	NULL
ug/ml	NULL
)	NULL
and	NULL
TPA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
8	NULL
h	NULL
(	NULL
ConA	NULL
+	NULL
TPA	NULL
)	NULL
before	NULL
cell	NULL
harvest	NULL
.	NULL

Relative	NULL
CAT	NULL
activitiees	NULL
of	NULL
Fyn	NULL
transfectants	NULL
in	NULL
comparison	NULL
with	NULL
mock	NULL
(	NULL
vector	NULL
)	NULL
transfectants	NULL
are	NULL
presented	NULL
.	NULL

Enhancer/promoter	NULL
IL-2	NULL
Fos	NULL
SRE	NULL
TRE	NULL
CRE	NULL
None	NULL
ConA	NULL
+	NULL
TPA	NULL
Vector	NULL
1.0	NULL
(	NULL
4.1	NULL
%	NULL
)	NULL
1.0	NULL
(	NULL
0.7	NULL
%	NULL
)	NULL
1.0	NULL
(	NULL
3.2	NULL
%	NULL
)	NULL
1.0	NULL
(	NULL
0.5	NULL
%	NULL
)	NULL
1.0	NULL
(	NULL
0.3	NULL
%	NULL
)	NULL
1.0	NULL
(	NULL
1.1	NULL
%	NULL
)	NULL
T-Fyn	NULL
2.2	NULL
9.6	NULL
1.8	NULL
1.3	NULL
1.0	NULL
4.2	NULL
T-FynF	NULL
5.7	NULL
20.4	NULL
4.0	NULL
2.7	NULL
1.1	NULL
9.2	NULL
B-Fyn	NULL
NT*	NULL
8.2	NULL
NT	NULL
NT	NULL
11	NULL
4.0	NULL
B-FynF	NULL
NT	NULL
13.2	NULL
NT	NULL
NT	NULL
NT	NULL
NT	NULL
£14	NULL
NT	NULL
12.7	NULL
NT	NULL
NT	NULL
1.1	NULL
5.7	NULL
t-1	NULL
NT	NULL
1.0	NULL
NT	NULL
NT	NULL
1.0	NULL
11	NULL
``	NULL
Numbers	NULL
in	NULL
percentage	NULL
indicate	NULL
values	NULL
of	NULL
percent	NULL
conversion	NULL
of	NULL
[	NULL
'*C	NULL
)	NULL
chloramphenicol	NULL
to	NULL
its	NULL
acetylated	NULL
form	NULL
.	NULL

All	NULL
values	NULL
were	NULL
average	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

°	NULL
NT	NULL
,	NULL
not	NULL
tested	NULL
.	NULL

2A	NULL
,	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
the	NULL
c-fos	NULL
promoter	NULL
was	NULL
activated	NULL
by	NULL
T-FynF	NULL
primarily	NULL
through	NULL
SRE	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
T-fyrF	NULL
showed	NULL
little	NULL
activation	NULL
of	NULL
CAT	NULL
activity	NULL
of	NULL
IL-2	NULL
CAT	NULL
over	NULL
the	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
vector	NULL
plasmid	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
elevated	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
alone	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
when	NULL
T-cells	NULL
cotransfected	NULL
with	NULL
IL-2	NULL
CAT	NULL
and	NULL
the	NULL
T-fynF	NULL
constructs	NULL
were	NULL
stimulated	NULL
simultaneously	NULL
by	NULL
TPA	NULL
and	NULL
a	NULL
mitogen	NULL
such	NULL
as	NULL
ConA	NULL
or	NULL
phytohemagglutinin	NULL
,	NULL
elevated	NULL
kinase	NULL
activity	NULL
of	NULL
T-FynF	NULL
markedly	NULL
stimulated	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

In	NULL
this	NULL
system	NULL
,	NULL
the	NULL
phorbol	NULL
ester	NULL
TPA	NULL
provided	NULL
a	NULL
second	NULL
signal	NULL
that	NULL
is	NULL
required	NULL
for	NULL
TCR-mediated	NULL
mitogenesis	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
cross-linked	NULL
the	NULL
CD3	NULL
molecule	NULL
with	NULL
anti-CD3e	NULL
antibodies	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
the	NULL
Jurkat	NULL
T-cells	NULL
that	NULL
had	NULL
been	NULL
transfected	NULL
with	NULL
the	NULL
IL-2	NULL
CAT	NULL
and	NULL
T-fyrF	NULL
constructs	NULL
.	NULL

On	NULL
TPA	NULL
treatment	NULL
,	NULL
CD3	NULL
cross-linking	NULL
induced	NULL
significant	NULL
transactivation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Treatment	NULL
with	NULL
TPA	NULL
and	NULL
anti-CD3e	NULL
without	NULL
exogenous	NULL
T-fyrF	NULL
had	NULL
little	NULL
effect	NULL
.	NULL

Thus	NULL
we	NULL
concluded	NULL
that	NULL
increased	NULL
kinase	NULL
activity	NULL
of	NULL
Fyn	NULL
augments	NULL
transcription	NULL
of	NULL
the	NULL
IL2	NULL
gene	NULL
upon	NULL
T-cell	NULL
activation	NULL
.	NULL

Effects	NULL
of	NULL
Normal	NULL
Fyn	NULL
,	NULL
Lock	NULL
,	NULL
and	NULL
Lyn	NULL
on	NULL
SRE	NULL
and	NULL
IL-2	NULL
Pro-moter-Previous	NULL
reports	NULL
show	NULL
that	NULL
active	NULL
forms	NULL
of	NULL
other	NULL
Sre	NULL
family	NULL
members	NULL
,	NULL
namely	NULL
F505	NULL
p56	NULL
``	NULL
**	NULL
(	NULL
36	NULL
)	NULL
and	NULL
v-Src	NULL
(	NULL
37	NULL
)	NULL
,	NULL
enhance	NULL
T-cell	NULL
responsiveness	NULL
.	NULL

As	NULL
p56	NULL
``	NULL
**	NULL
is	NULL
abundantly	NULL
expressed	NULL
in	NULL
T-cells	NULL
and	NULL
can	NULL
contribute	NULL
to	NULL
T-cell	NULL
signaling	NULL
(	NULL
3-5	NULL
,	NULL
38	NULL
)	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
clarify	NULL
whether	NULL
Fyn	NULL
and	NULL
Lok	NULL
regulate	NULL
the	NULL
signaling	NULL
through	NULL
similar	NULL
or	NULL
different	NULL
mechanisms	NULL
.	NULL

Then	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
normal	NULL
Fyn	NULL
and	NULL
normal	NULL
Lck	NULL
on	NULL
SRE	NULL
and	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

For	NULL
comparison	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
lyn	NULL
gene	NULL
prod-uct	NULL
,	NULL
which	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
normal	NULL
T-cells	NULL
,	NULL
was	NULL
also	NULL
tested	NULL
.	NULL

Two	NULL
forms	NULL
of	NULL
normal	NULL
fyn	NULL
cDNAs	NULL
,	NULL
T-fyn	NULL
and	NULL
B-fyn	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
(	NULL
22	NULL
)	NULL
,	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
SRECAT	NULL
and	NULL
caused	NULL
stimulation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
only	NULL
when	NULL
the	NULL
transfectants	NULL
were	NULL
stimulated	NULL
with	NULL
TPA	NULL
plus	NULL
ConA	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

No	NULL
significant	NULL
difference	NULL
was	NULL
observed	NULL
between	NULL
T-fyn	NULL
and	NULL
B-fyn	NULL
.	NULL

SRE	NULL
was	NULL
also	NULL
stimulated	NULL
by	NULL
normal	NULL
and	NULL
active	NULL
F505Lck	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
as	NULL
c-fos	NULL
CAT	NULL
was	NULL
transactivated	NULL
by	NULL
Lck	NULL
to	NULL
a	NULL
similar	NULL
extent	NULL
as	NULL
by	NULL
Fyn	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
we	NULL
tentatively	NULL
concluded	NULL
that	NULL
the	NULL
c-fos	NULL
gene	NULL
is	NULL
also	NULL
regulated	NULL
by	NULL
Lek	NULL
most	NULL
likely	NULL
through	NULL
SRE	NULL
on	NULL
T-cell	NULL
activation	NULL
.	NULL

Active	NULL
Lyn	NULL
(	NULL
F508Lyn	NULL
)	NULL
also	NULL
stimulated	NULL
SRE	NULL
,	NULL
while	NULL
normal	NULL
Lyn	NULL
had	NULL
only	NULL
a	NULL
slight	NULL
effect	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
were	NULL
substantiated	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
introduction	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
fyn	NULL
and	NULL
Ick	NULL
constructs	NULL
,	NULL
but	NULL
not	NULL
the	NULL
lyn	NULL
construct	NULL
,	NULL
stimulated	NULL
SRE	NULL
dose	NULL
dependently	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
found	NULL
that	NULL
neither	NULL
normal	NULL
Lek	NULL
nor	NULL
Lyn	NULL
activated	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
ConA	NULL
plus	NULL
TPA	NULL
stimulation	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

When	NULL
the	NULL
amounts	NULL
of	NULL
the	NULL
expression	NULL
constructs	NULL
were	NULL
increased	NULL
,	NULL
the	NULL
level	NULL
of	NULL
transactivation	NULL
A	NULL
\0	NULL
(	NULL
°	NULL
«	NULL
Qg/	NULL
QQ	NULL
‘	NULL
Q/	NULL
(	NULL
``	NULL
OQSO	NULL
KOO	NULL
)	NULL
«	NULL
Qg/	NULL
OQQ/	NULL
$	NULL
8	NULL
;	NULL
vector	NULL
TFynF	NULL
1	NULL
[	NULL
_	NULL
I	NULL
«	NULL
im	NULL
TTH	NULL
chas	NULL
Tak	NULL
f	NULL
B	NULL
X	NULL
%	NULL
o	NULL
<	NULL
¥	NULL
0	NULL
©	NULL
10	NULL
0	NULL
%	NULL
@	NULL
@	NULL
#	NULL
0	NULL
@	NULL
+0	NULL
0	NULL
%	NULL
@	NULL
+	NULL
0	NULL
0	NULL
@	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Stimulation	NULL
of	NULL
c-fos	NULL
promoter	NULL
and	NULL
SRE	NULL
by	NULL
Fyn	NULL
and	NULL
Lek	NULL
.	NULL

A	NULL
,	NULL
effect	NULL
of	NULL
T-FynF	NULL
.	NULL

The	NULL
expression	NULL
plasmids	NULL
pME18SM	NULL
(	NULL
5	NULL
ug/reaction	NULL
)	NULL
with	NULL
(	NULL
Zanes	NULL
5-8	NULL
)	NULL
or	NULL
without	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
T-fynF	NULL
cDNA	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T-cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
)	NULL
together	NULL
with	NULL
reporter	NULL
plasmids	NULL
(	NULL
5	NULL
ug	NULL
each	NULL
)	NULL
,	NULL
c-fos	NULL
CAT	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
,	NULL
TRECAT	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
,	NULL
CRECAT	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
,	NULL
and	NULL
SRECAT	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
.	NULL

The	NULL
lysates	NULL
(	NULL
80	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
of	NULL
the	NULL
transfectants	NULL
were	NULL
subjected	NULL
to	NULL
CAT	NULL
assay	NULL
.	NULL

B	NULL
,	NULL
the	NULL
expression	NULL
plasmids	NULL
pME18SM	NULL
(	NULL
5	NULL
pg/reaction	NULL
)	NULL
containing	NULL
cDNAs	NULL
for	NULL
normal	NULL
T-Fyn	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
mutant	NULL
T-FynF	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
normal	NULL
Lok	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
mutant	NULL
F505Lck	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
or	NULL
no	NULL
insert	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T-cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
)	NULL
together	NULL
with	NULL
c-fos	NULL
CAT	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
.	NULL

The	NULL
lysates	NULL
(	NULL
80	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
of	NULL
the	NULL
transfectants	NULL
were	NULL
subjected	NULL
to	NULL
CAT	NULL
assay	NULL
.	NULL

of	NULL
the	NULL
IL2	NULL
promoter	NULL
by	NULL
normal	NULL
Lek	NULL
or	NULL
Lyn	NULL
kinase	NULL
remained	NULL
low	NULL
,	NULL
while	NULL
that	NULL
by	NULL
normal	NULL
Fyn	NULL
increased	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
fyn	NULL
construct	NULL
transfected	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

From	NULL
these	NULL
data	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
Fyn	NULL
is	NULL
a	NULL
key	NULL
protein-tyrosine	NULL
kinase	NULL
involved	NULL
in	NULL
the	NULL
process	NULL
of	NULL
T-cell	NULL
activation	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
,	NULL
however	NULL
,	NULL
that	NULL
both	NULL
active	NULL
F505Lck	NULL
(	NULL
LekF	NULL
)	NULL
and	NULL
F508Lyn	NULL
(	NULL
LynF	NULL
)	NULL
together	NULL
with	NULL
ConA	NULL
plus	NULL
TPA	NULL
stimulated	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
,	NULL
though	NULL
less	NULL
significantly	NULL
than	NULL
Fyn	NULL
.	NULL

Importance	NULL
of	NULL
Fyn	NULL
SH2	NULL
Domain	NULL
in	NULL
Signaling-In	NULL
order	NULL
to	NULL
27416	NULL
2.0	NULL
E	NULL
1.5	NULL
f	NULL
&	NULL
g	NULL
1.0	NULL
&	NULL
S	NULL
0.5	NULL
con	NULL
d	NULL
d	NULL
TPA	NULL
-	NULL
+	NULL
e	NULL
-+	NULL
aCD3e	NULL
--	NULL
-=	NULL
~	NULL
}	NULL
~	NULL
}	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Stimulation	NULL
of	NULL
IL-2	NULL
promoter	NULL
upon	NULL
cross-linking	NULL
of	NULL
CD3e	NULL
.	NULL

The	NULL
expression	NULL
plasmids	NULL
pME18SM	NULL
(	NULL
5	NULL
ug/reaction	NULL
)	NULL
with	NULL
(	NULL
shaded	NULL
bars	NULL
)	NULL
or	NULL
without	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
T-fyrF	NULL
cDNA	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T-cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
)	NULL
together	NULL
with	NULL
IL-2	NULL
CAT	NULL
constructs	NULL
(	NULL
5	NULL
ug	NULL
each	NULL
)	NULL
.	NULL

The	NULL
transfectants	NULL
were	NULL
treated	NULL
with	NULL
TPA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
and	NULL
anti-CD3e	NULL
antibodies	NULL
(	NULL
50	NULL
ng/ml	NULL
,	NULL
provided	NULL
by	NULL
T.	NULL
Uchiyama	NULL
,	NULL
Kyoto	NULL
University	NULL
)	NULL
for	NULL
6	NULL
h	NULL
before	NULL
cell	NULL
harvest	NULL
as	NULL
described	NULL
(	NULL
55	NULL
)	NULL
.	NULL

The	NULL
lysates	NULL
of	NULL
these	NULL
transfectants	NULL
were	NULL
subjected	NULL
to	NULL
CAT	NULL
assay	NULL
.	NULL

Tasue	NULL
II	NULL
Stimulation	NULL
of	NULL
SRE	NULL
and	NULL
IL-2	NULL
promoter	NULL
by	NULL
Lok	NULL
and	NULL
Lyn	NULL
Both	NULL
normal	NULL
and	NULL
active	NULL
/ck	NULL
or	NULL
lyn	NULL
cDNAs	NULL
in	NULL
pME18SM	NULL
vector	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T-cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
)	NULL
together	NULL
with	NULL
reporter	NULL
plasmids	NULL
,	NULL
SRECAT	NULL
(	NULL
SRE	NULL
)	NULL
,	NULL
or	NULL
IL-2	NULL
CAT	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

The	NULL
lysates	NULL
(	NULL
80	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
of	NULL
the	NULL
transfectants	NULL
were	NULL
subjected	NULL
to	NULL
CAT	NULL
assay	NULL
,	NULL
and	NULL
the	NULL
enhancer/promoter	NULL
activities	NULL
were	NULL
shown	NULL
as	NULL
described	NULL
in	NULL
Table	NULL
I.	NULL
Enhancer/promoter	NULL
SRE	NULL
IL-2	NULL
None	NULL
ConA	NULL
+	NULL
TPA	NULL
Vector	NULL
1.0	NULL
(	NULL
0.8	NULL
%	NULL
)	NULL
1.0	NULL
(	NULL
0.5	NULL
%	NULL
)	NULL
1.0	NULL
(	NULL
1.2	NULL
%	NULL
)	NULL
Lck	NULL
5.9	NULL
11	NULL
1.0	NULL
LckF	NULL
8.8	NULL
1.0	NULL
3.4	NULL
Lyn	NULL
2.2	NULL
1.0	NULL
0.9	NULL
LynF	NULL
3.1	NULL
1.0	NULL
2.8	NULL
dissect	NULL
further	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
T-cell	NULL
responsiveness	NULL
by	NULL
Fyn	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
Fyn	NULL
mutants	NULL
on	NULL
SRE	NULL
and	NULL
IL-2	NULL
promoters	NULL
.	NULL

Two	NULL
mutants	NULL
of	NULL
B-fynr	NULL
,	NULL
f-14	NULL
and	NULL
t-l1fyns	NULL
,	NULL
which	NULL
we	NULL
isolated	NULL
before	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
transform	NULL
chicken	NULL
embryo	NULL
fibroblasts	NULL
while	NULL
normal	NULL
fyn	NULL
does	NULL
not	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
products	NULL
of	NULL
these	NULL
mutant	NULL
fyn	NULL
genes	NULL
were	NULL
shown	NULL
to	NULL
have	NULL
elevated	NULL
protein-tyrosine	NULL
kinase	NULL
activities	NULL
in	NULL
vitro	NULL
(	NULL
(	NULL
21	NULL
)	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
mechanisms	NULL
of	NULL
activation	NULL
seem	NULL
to	NULL
be	NULL
different	NULL
because	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
mutations	NULL
in	NULL
the	NULL
genes	NULL
are	NULL
different	NULL
from	NULL
each	NULL
other	NULL
.	NULL

The	NULL
£-14	NULL
mutant	NULL
carries	NULL
a	NULL
point	NULL
mutation	NULL
resulting	NULL
in	NULL
Thr-338	NULL
instead	NULL
of	NULL
in	NULL
the	NULL
kinase	NULL
domain	NULL
.	NULL

The	NULL
t-1	NULL
mutant	NULL
carries	NULL
deletions	NULL
of	NULL
78	NULL
base	NULL
pairs	NULL
in	NULL
the	NULL
sequence	NULL
encoding	NULL
the	NULL
Sre	NULL
homology-2	NULL
(	NULL
SH2	NULL
)	NULL
region	NULL
.	NULL

The	NULL
product	NULL
of	NULL
£-14fyn	NULL
stimulated	NULL
the	NULL
CAT	NULL
activity	NULL
of	NULL
SRECAT	NULL
,	NULL
and	NULL
the	NULL
stimulation	NULL
was	NULL
greater	NULL
than	NULL
that	NULL
by	NULL
normal	NULL
Fyn	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
t-1fyn	NULL
did	NULL
not	NULL
transactivate	NULL
SRE	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

The	NULL
possibility	NULL
that	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
t-1fyn	NULL
was	NULL
much	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
normal	NULL
fyn	NULL
or	NULL
£-14fyn	NULL
in	NULL
transfected	NULL
cells	NULL
is	NULL
unlikely	NULL
for	NULL
the	NULL
following	NULL
reasons	NULL
.	NULL

First	NULL
all	NULL
the	NULL
B-fyn	NULL
constructs	NULL
,	NULL
the	NULL
wild	NULL
type	NULL
,	NULL
f-14	NULL
,	NULL
and	NULL
t-1	NULL
,	NULL
directed	NULL
almost	NULL
the	NULL
same	NULL
level	NULL
of	NULL
Fyn	NULL
expression	NULL
when	NULL
transfected	NULL
into	NULL
CV-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
in	NULL
which	NULL
the	NULL
level	NULL
of	NULL
en-dogenous	NULL
Fyn	NULL
is	NULL
low	NULL
.	NULL

Second	NULL
,	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
SH2	NULL
deletion	NULL
mutant	NULL
t-1	NULL
expressed	NULL
a	NULL
significant	NULL
amount	NULL
of	NULL
the	NULL
exogenous	NULL
Fyn	NULL
protein	NULL
as	NULL
determined	NULL
by	NULL
immune	NULL
complex	NULL
kinase	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
even	NULL
when	NULL
the	NULL
increased	NULL
amounts	NULL
of	NULL
the	NULL
t-1fyn	NULL
construct	NULL
were	NULL
cotransfected	NULL
,	NULL
the	NULL
CAT	NULL
activity	NULL
of	NULL
SRECAT	NULL
remained	NULL
at	NULL
low	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
SH2	NULL
region	NULL
seems	NULL
important	NULL
in	NULL
Fyn-mediated	NULL
transactivation	NULL
of	NULL
SRE	NULL
.	NULL

Similarly	NULL
the	NULL
CAT	NULL
activity	NULL
of	NULL
IL-2	NULL
CAT	NULL
was	NULL
stimulated	NULL
by	NULL
f-14	NULL
Fyn	NULL
but	NULL
not	NULL
by	NULL
t-1Fyn	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
in	NULL
Jurkat	NULL
cells	NULL
treated	NULL
by	NULL
ConA	NULL
Regulation	NULL
of	NULL
T-cell	NULL
Signaling	NULL
by	NULL
Protein-tyrosine	NULL
Kinases	NULL
A	NULL
3	NULL
-	NULL
@	NULL
-	NULL
T-fyn	NULL
>	NULL
-a-	NULL
lyn	NULL
_	NULL
aA	NULL
E	NULL
-	NULL
#	NULL
-	NULL
Ick	NULL
l	NULL
g	NULL
-O-	NULL
t-1	NULL
fyn	NULL
<	NULL
0	NULL
2	NULL
Fa	NULL
<	NULL
U	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
o	NULL
00	NULL
|	NULL
-	NULL
wen	NULL
``	NULL
3	NULL
l	NULL
1	NULL
``	NULL
C	NULL
P4	NULL
0	NULL
7T	NULL
%	NULL
}	NULL
}	NULL
Fm	NULL
;	NULL
°	NULL
'	NULL
8	NULL
10	NULL
Expression	NULL
Plasmid	NULL
9	NULL
B	NULL
s	NULL
+T-fyn	NULL
3	NULL
4	NULL
-~	NULL
#	NULL
lyn	NULL
B	NULL
-	NULL
@	NULL
-	NULL
lek	NULL
<	NULL
t	NULL
3	NULL
<	NULL
J	NULL
o	NULL
2	NULL
a	NULL
3	NULL
&	NULL
a	NULL
i	NULL
.	NULL

ne	NULL
Ko	NULL
o	NULL
l	NULL
n	NULL
p	NULL
gie	NULL
nin	NULL
b	NULL
tt	NULL
zz	NULL
ws	NULL
is	NULL
sessa	NULL
ee	NULL
ak	NULL
4	NULL
n*	NULL
*	NULL
m	NULL
0	NULL
-	NULL
}	NULL
}	NULL
;	NULL
,	NULL
{	NULL
'	NULL
10	NULL
4	NULL
,	NULL
6	NULL
_	NULL
.	NULL

8	NULL
Expression	NULL
Plasmid	NULL
u	NULL
g	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Differential	NULL
effects	NULL
of	NULL
Src-like	NULL
kinases	NULL
on	NULL
SRE	NULL
and	NULL
IL-2	NULL
promoter	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
the	NULL
cDNAs	NULL
for	NULL
T-Fyn	NULL
,	NULL
Lek	NULL
(	NULL
25	NULL
)	NULL
,	NULL
and	NULL
Lyn	NULL
(	NULL
13	NULL
)	NULL
cloned	NULL
in	NULL
pME18SM	NULL
(	NULL
1-9	NULL
ug	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
108	NULL
cells	NULL
)	NULL
together	NULL
with	NULL
SRECAT	NULL
(	NULL
3	NULL
ug	NULL
)	NULL
(	NULL
A	NULL
)	NULL
or	NULL
with	NULL
IL-2	NULL
CAT	NULL
(	NULL
3	NULL
ug	NULL
)	NULL
(	NULL
B	NULL
)	NULL
.	NULL

In	NULL
B	NULL
,	NULL
transfectants	NULL
were	NULL
treated	NULL
with	NULL
ConA	NULL
and	NULL
TPA	NULL
as	NULL
described	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

The	NULL
lysates	NULL
of	NULL
these	NULL
transfectants	NULL
were	NULL
subjected	NULL
to	NULL
CAT	NULL
assay	NULL
.	NULL

In	NULL
A	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
t-1Fyn	NULL
was	NULL
also	NULL
analyzed	NULL
by	NULL
transfecting	NULL
its	NULL
cDNA	NULL
in	NULL
pME18SM	NULL
.	NULL

Three	NULL
independent	NULL
experiments	NULL
gave	NULL
virtually	NULL
identical	NULL
results	NULL
.	NULL

The	NULL
percentage	NULL
conversions	NULL
of	NULL
[	NULL
**C	NULL
)	NULL
chloramphenicol	NULL
to	NULL
its	NULL
acetylated	NULL
form	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
expression	NULL
plasmids	NULL
of	NULL
fyn	NULL
,	NULL
ick	NULL
,	NULL
and	NULL
lyn	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
a	NULL
particular	NULL
experiment	NULL
were	NULL
,	NULL
respectively	NULL
,	NULL
0.7	NULL
,	NULL
0.6	NULL
,	NULL
and	NULL
0.9	NULL
in	NULL
A	NULL
and	NULL
0.45	NULL
,	NULL
0.2	NULL
,	NULL
and	NULL
0.3	NULL
in	NULL
B	NULL
.	NULL

The	NULL
data	NULL
with	NULL
t-lfyn	NULL
(	NULL
A	NULL
)	NULL
were	NULL
obtained	NULL
with	NULL
a	NULL
different	NULL
set	NULL
of	NULL
experiments	NULL
,	NULL
and	NULL
the	NULL
percentage	NULL
conversion	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
DNA	NULL
was	NULL
0.66	NULL
.	NULL

3	NULL
4	NULL
mm	NULL
x-	NULL
Fyn	NULL
A	NULL
|	NULL
2	NULL
»	NULL
Fyn	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
t-1fyn	NULL
in	NULL
fibroblasts	NULL
and	NULL
T-cells	NULL
.	NULL

Expression	NULL
plasmids	NULL
pME18SM	NULL
containing	NULL
cDNAs	NULL
for	NULL
normal	NULL
B-fyr	NULL
(	NULL
lanes	NULL
A4	NULL
and	NULL
B4	NULL
)	NULL
,	NULL
f-14fyn	NULL
(	NULL
lanes	NULL
A3	NULL
and	NULL
B3	NULL
)	NULL
,	NULL
and	NULL
t-1fyn	NULL
(	NULL
lanes	NULL
A2	NULL
and	NULL
B2	NULL
)	NULL
or	NULL
no	NULL
insert	NULL
(	NULL
lanes	NULL
A1	NULL
and	NULL
B1	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
CV-1	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
and	NULL
Jurkat	NULL
T-cells	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
transfectants	NULL
were	NULL
harvested	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
lysed	NULL
with	NULL
RIPA	NULL
buffer	NULL
,	NULL
and	NULL
the	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
A	NULL
)	NULL
or	NULL
to	NULL
immune	NULL
complex	NULL
kinase	NULL
assay	NULL
(	NULL
B	NULL
)	NULL
using	NULL
anti-Fyn	NULL
antibodies	NULL
.	NULL

The	NULL
position	NULL
of	NULL
Fyn	NULL
is	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

Only	NULL
a	NULL
slight	NULL
difference	NULL
of	NULL
migration	NULL
between	NULL
t-1Fyn	NULL
and	NULL
normal	NULL
or	NULL
£-14Fyn	NULL
is	NULL
acknowledged	NULL
in	NULL
B	NULL
,	NULL
since	NULL
the	NULL
kinase	NULL
reaction	NULL
products	NULL
were	NULL
analyzed	NULL
in	NULL
SDS-polyacrylamide	NULL
gel	NULL
containing	NULL
a	NULL
relatively	NULL
higher	NULL
concentration	NULL
(	NULL
12	NULL
%	NULL
)	NULL
of	NULL
polyacrylamide	NULL
.	NULL

plus	NULL
TPA	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
Fyn	NULL
kinase	NULL
enhances	NULL
signaling	NULL
into	NULL
the	NULL
nucleus	NULL
and	NULL
further	NULL
that	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Fyn	NULL
is	NULL
involved	NULL
in	NULL
this	NULL
enhancement	NULL
.	NULL

Functional	NULL
and	NULL
Physical	NULL
Interactions	NULL
of	NULL
Fyn	NULL
with	NULL
Csk	NULL
in	NULL
TCR-mediated	NULL
Signaling-To	NULL
determine	NULL
the	NULL
effects	NULL
of	NULL
Csk	NULL
on	NULL
transactivation	NULL
of	NULL
c-fos	NULL
and	NULL
IL-2	NULL
promoters	NULL
by	NULL
Src-like	NULL
kinases	NULL
,	NULL
we	NULL
inserted	NULL
csk	NULL
cDNA	NULL
(	NULL
26	NULL
)	NULL
in	NULL
the	NULL
correct	NULL
and	NULL
reverse	NULL
orienta-	NULL
Regulation	NULL
of	NULL
T-cell	NULL
Signaling	NULL
by	NULL
Protein-tyrosine	NULL
Kinases	NULL
1°	NULL
2	NULL
34	NULL
56	NULL
78	NULL
310	NULL
A	NULL
7	NULL
%	NULL
Acetylation	NULL
%	NULL
Acetylation	NULL
vector	NULL
T-Fyn	NULL
T-FynF	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Interaction	NULL
of	NULL
Csk	NULL
with	NULL
Fyn	NULL
and	NULL
Lek	NULL
.	NULL

Samples	NULL
of	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
expression	NULL
plasmid	NULL
pMECsk	NULL
(	NULL
sense	NULL
;	NULL
+	NULL
,	NULL
shaded	NULL
bars	NULL
)	NULL
or	NULL
pMEKsc	NULL
(	NULL
antisense	NULL
;	NULL
-	NULL
,	NULL
solid	NULL
bars	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T-cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
together	NULL
with	NULL
the	NULL
expression	NULL
plasmids	NULL
(	NULL
3	NULL
ug	NULL
)	NULL
for	NULL
normal	NULL
T-Fyn	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
normal	NULL
Lok	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
activated	NULL
T-FynF	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
or	NULL
activated	NULL
LckF	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
and	NULL
SRECAT	NULL
(	NULL
A	NULL
)	NULL
or	NULL
IL-2	NULL
CAT	NULL
(	NULL
B	NULL
)	NULL
reporter	NULL
plasmid	NULL
(	NULL
3	NULL
ug	NULL
)	NULL
.	NULL

When	NULL
the	NULL
IL-2	NULL
CAT	NULL
construct	NULL
was	NULL
used	NULL
as	NULL
a	NULL
reporter	NULL
plasmid	NULL
,	NULL
the	NULL
transfectants	NULL
were	NULL
treated	NULL
with	NULL
ConA	NULL
and	NULL
TPA	NULL
as	NULL
described	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

The	NULL
pMECsk	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
pMEKsc	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
plasmid	NULL
(	NULL
3	NULL
ug	NULL
)	NULL
was	NULL
transfected	NULL
with	NULL
the	NULL
reporter	NULL
plasmids	NULL
(	NULL
3	NULL
ug	NULL
)	NULL
and	NULL
pME18SM	NULL
vector	NULL
plasmid	NULL
without	NULL
fyr	NULL
cDNA	NULL
(	NULL
3	NULL
ug	NULL
)	NULL
.	NULL

At	NULL
least	NULL
two	NULL
independent	NULL
experiments	NULL
gave	NULL
essentially	NULL
identical	NULL
results	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
data	NULL
with	NULL
antisense	NULL
csk	NULL
cDNA	NULL
in	NULL
this	NULL
experiment	NULL
were	NULL
consistent	NULL
with	NULL
those	NULL
given	NULL
in	NULL
Tables	NULL
I	NULL
and	NULL
II	NULL
except	NULL
that	NULL
the	NULL
level	NULL
of	NULL
stimulation	NULL
of	NULL
SRE	NULL
by	NULL
LckF	NULL
was	NULL
relatively	NULL
lower	NULL
than	NULL
that	NULL
by	NULL
Lok	NULL
.	NULL

Probably	NULL
this	NULL
could	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
poorer	NULL
quality	NULL
of	NULL
the	NULL
LckF	NULL
plasmid	NULL
that	NULL
we	NULL
prepared	NULL
for	NULL
this	NULL
particular	NULL
experiment	NULL
.	NULL

tions	NULL
under	NULL
the	NULL
SRa	NULL
«	NULL
promoter	NULL
and	NULL
transfected	NULL
the	NULL
resulting	NULL
constructs	NULL
into	NULL
Jurkat	NULL
cells	NULL
together	NULL
with	NULL
the	NULL
reporter	NULL
CAT	NULL
constructs	NULL
and	NULL
the	NULL
fyn	NULL
or	NULL
Ick	NULL
expression	NULL
construct	NULL
.	NULL

Expression	NULL
of	NULL
sense	NULL
csk	NULL
cDNA	NULL
suppressed	NULL
normal	NULL
Fyn-	NULL
or	NULL
Lek-mediated	NULL
stimulation	NULL
of	NULL
SRE	NULL
,	NULL
while	NULL
expression	NULL
of	NULL
antisense	NULL
csk	NULL
cDNA	NULL
had	NULL
virtually	NULL
no	NULL
effect	NULL
on	NULL
SRE	NULL
stimulation	NULL
by	NULL
Lek	NULL
and	NULL
Fyn	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
SRE	NULL
stimulation	NULL
by	NULL
the	NULL
active	NULL
forms	NULL
of	NULL
these	NULL
kinases	NULL
with	NULL
tyrosine	NULL
to	NULL
phenylalanine	NULL
mutations	NULL
at	NULL
the	NULL
carboxyl-terminal	NULL
phosphorylation	NULL
sites	NULL
(	NULL
T-FynF	NULL
and	NULL
LckF	NULL
)	NULL
was	NULL
barely	NULL
affected	NULL
by	NULL
Csk	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
by	NULL
normal	NULL
Fyn	NULL
was	NULL
also	NULL
suppressed	NULL
by	NULL
Csk	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Again	NULL
T-FynF-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
promoter	NULL
was	NULL
little	NULL
affected	NULL
by	NULL
Csk	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
Csk	NULL
is	NULL
involved	NULL
in	NULL
TCR-mediated	NULL
signaling	NULL
by	NULL
regulating	NULL
the	NULL
kinase	NULL
activities	NULL
of	NULL
Fyn	NULL
and	NULL
Lek	NULL
to	NULL
stimulate	NULL
the	NULL
c-fos	NULL
and/or	NULL
IL-2	NULL
promoters	NULL
.	NULL

Then	NULL
the	NULL
possibility	NULL
that	NULL
Csk	NULL
physically	NULL
interacts	NULL
with	NULL
Fyn	NULL
was	NULL
ex	NULL
27417	NULL
A	NULL
10	NULL
2	NULL
o	NULL
:	NULL
40	NULL
506	NULL
kDa	NULL
200	NULL
-	NULL
f	NULL
97.4	NULL
69.0	NULL
-	NULL
w	NULL
*	NULL
--	NULL
<	NULL
<	NULL
46.0	NULL
-	NULL
C	NULL
*	NULL
$	NULL
i	NULL
<	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Co-immunoprecipitation	NULL
of	NULL
Fyn	NULL
with	NULL
Csk	NULL
.	NULL

The	NULL
HBC21.7.31	NULL
cells	NULL
and	NULL
their	NULL
derivatives	NULL
(	NULL
10°	NULL
)	NULL
that	NULL
express	NULL
normal	NULL
B-Fyn	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
and	NULL
£-14Fyn	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
exogenously	NULL
were	NULL
lysed	NULL
with	NULL
TNE	NULL
buffer	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
immune	NULL
complex	NULL
kinase	NULL
assay	NULL
using	NULL
normal	NULL
rabbit	NULL
serum	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
or	NULL
anti-Csk	NULL
antibodies	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

The	NULL
Fyn	NULL
protein	NULL
was	NULL
then	NULL
re-immunoprecipitated	NULL
from	NULL
the	NULL
reaction	NULL
products	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
Western	NULL
blotting	NULL
to	NULL
examine	NULL
the	NULL
amount	NULL
of	NULL
Fyn	NULL
(	NULL
B	NULL
)	NULL
and	NULL
Csk	NULL
(	NULL
C	NULL
)	NULL
expressed	NULL
in	NULL
each	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
Fyn	NULL
and	NULL
Csk	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
by	NULL
arrows	NULL
.	NULL

amined	NULL
using	NULL
the	NULL
T-cell	NULL
hybridomas	NULL
HBC21.7.31	NULL
in	NULL
which	NULL
normal	NULL
or	NULL
f-14fyn	NULL
was	NULL
exogenously	NULL
introduced	NULL
.	NULL
``	NULL

From	NULL
lysates	NULL
of	NULL
both	NULL
normal	NULL
fyn	NULL
and	NULL
£-14fyn	NULL
overexpressed	NULL
cells	NULL
,	NULL
we	NULL
could	NULL
co-immunoprecipitate	NULL
Fyn	NULL
with	NULL
Csk	NULL
using	NULL
anti-Csk	NULL
antibodies	NULL
,	NULL
which	NULL
was	NULL
demonstrated	NULL
by	NULL
in	NULL
vitro	NULL
kinase	NULL
reaction	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
Fyn	NULL
co-immunoprecipitated	NULL
with	NULL
Csk	NULL
was	NULL
apparently	NULL
dependent	NULL
on	NULL
the	NULL
level	NULL
of	NULL
Fyn	NULL
expression	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

More	NULL
phosphorylation	NULL
of	NULL
f-14Fyn	NULL
as	NULL
compared	NULL
with	NULL
normal	NULL
Fyn	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
Csk	NULL
immunoprecipitates	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

This	NULL
may	NULL
suggest	NULL
that	NULL
£-14Fyn	NULL
that	NULL
is	NULL
supposed	NULL
to	NULL
be	NULL
highly	NULL
autophosphorylated	NULL
at	NULL
Tyr-420	NULL
in	NULL
vivo	NULL
forms	NULL
a	NULL
stabler	NULL
complex	NULL
with	NULL
Csk	NULL
than	NULL
normal	NULL
Fyn	NULL
.	NULL

The	NULL
associated	NULL
Csk	NULL
would	NULL
phosphorylate	NULL
Fyn	NULL
in	NULL
vitro	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
both	NULL
forms	NULL
of	NULL
Fyn	NULL
equally	NULL
associate	NULL
with	NULL
Fyn	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
phosphorylation	NULL
merely	NULL
reflect	NULL
the	NULL
in	NULL
vitro	NULL
kinase	NULL
activities	NULL
of	NULL
£-14Fyn	NULL
and	NULL
normal	NULL
Fyn	NULL
.	NULL

Our	NULL
experimental	NULL
data	NULL
do	NULL
not	NULL
discriminate	NULL
these	NULL
two	NULL
possibilities	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
examine	NULL
whether	NULL
phosphorylation	NULL
in	NULL
vitro	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
occurred	NULL
on	NULL
Tyr-420	NULL
or	NULL
on	NULL
Tyr-531	NULL
in	NULL
order	NULL
to	NULL
further	NULL
analyze	NULL
the	NULL
mechanism	NULL
of	NULL
association	NULL
.	NULL

Nonetheless	NULL
our	NULL
data	NULL
at	NULL
least	NULL
demonstrate	NULL
physical	NULL
association	NULL
of	NULL
Fyn	NULL
with	NULL
Csk	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
Csk	NULL
is	NULL
involved	NULL
in	NULL
TCR-mediated	NULL
signaling	NULL
.	NULL

DISCUSSION	NULL
Using	NULL
a	NULL
transient	NULL
expression	NULL
system	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
Fyn	NULL
kinase	NULL
activated	NULL
by	NULL
a	NULL
point	NULL
mutation	NULL
,	NULL
Tyr-528	NULL
-	NULL
>	NULL
Phe	NULL
,	NULL
confers	NULL
hyperresponsiveness	NULL
on	NULL
T-cells	NULL
.	NULL

The	NULL
T-cell	NULL
responsiveness	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
stimulation	NULL
of	NULL
the	NULL
promoter	NULL
activities	NULL
of	NULL
both	NULL
the	NULL
c-fos	NULL
and	NULL
IL-2	NULL
genes	NULL
.	NULL

Our	NULL
evidence	NULL
suggests	NULL
that	NULL
the	NULL
c-fos	NULL
promoter	NULL
is	NULL
stimulated	NULL
by	NULL
T-FynF	NULL
through	NULL
enhancement	NULL
of	NULL
SRE	NULL
and	NULL
TRE	NULL
within	NULL
the	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

The	NULL
IL-2	NULL
promoter	NULL
activity	NULL
was	NULL
augmented	NULL
by	NULL
T-FynF	NULL
only	NULL
when	NULL
the	NULL
cells	NULL
received	NULL
mitogenic	NULL
stimulation	NULL
that	NULL
mimics	NULL
TCR-mediated	NULL
activation	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
elevated	NULL
kinase	NULL
activity	NULL
alone	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
deliver	NULL
the	NULL
signal	NULL
toward	NULL
the	NULL
nucleus	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
T-cell	NULL
specific	NULL
signaling	NULL
through	NULL
Fyn	NULL
may	NULL
require	NULL
its	NULL
dimerization	NULL
,	NULL
as	NULL
the	NULL
signaling	NULL
of	NULL
the	NULL
receptor-type	NULL
protein-tyrosine	NULL
kinase	NULL
occurs	NULL
via	NULL
27418	NULL
dimerization	NULL
of	NULL
the	NULL
receptor	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Since	NULL
Fyn	NULL
interacts	NULL
with	NULL
TCR	NULL
complex	NULL
,	NULL
ligand-dependent	NULL
clustering	NULL
of	NULL
TCR	NULL
would	NULL
result	NULL
in	NULL
Fyn	NULL
dimerization	NULL
.	NULL

Similar	NULL
,	NULL
though	NULL
less	NULL
,	NULL
stimulation	NULL
of	NULL
these	NULL
promoters	NULL
was	NULL
observed	NULL
by	NULL
overexpressing	NULL
normal	NULL
Fyn	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
kinase-active	NULL
Fyn	NULL
having	NULL
a	NULL
deletion	NULL
in	NULL
the	NULL
SH2	NULL
region	NULL
could	NULL
hardly	NULL
stimulate	NULL
SRE	NULL
or	NULL
affect	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
activating	NULL
signal	NULL
(	NULL
Table	NULL
I	NULL
,	NULL
see	NULL
below	NULL
)	NULL
.	NULL

From	NULL
these	NULL
data	NULL
we	NULL
have	NULL
concluded	NULL
that	NULL
Fyn	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
delivering	NULL
signal	NULL
from	NULL
TCR	NULL
to	NULL
nucleus	NULL
.	NULL

In	NULL
addition	NULL
we	NULL
would	NULL
like	NULL
to	NULL
point	NULL
out	NULL
that	NULL
the	NULL
experimental	NULL
system	NULL
employed	NULL
in	NULL
this	NULL
study	NULL
is	NULL
useful	NULL
to	NULL
analyze	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
Fyn	NULL
function	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Namely	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
to	NULL
coexpress	NULL
possible	NULL
regulatory	NULL
proteins	NULL
such	NULL
as	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
Csk	NULL
and	NULL
protein	NULL
tyrosine	NULL
phosphatases	NULL
together	NULL
with	NULL
Fyn	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
examine	NULL
the	NULL
activities	NULL
of	NULL
c-fos	NULL
and	NULL
IL-2	NULL
promoters	NULL
in	NULL
T-cell	NULL
signaling	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

The	NULL
suggestion	NULL
of	NULL
functional	NULL
involvement	NULL
of	NULL
Fyn	NULL
in	NULL
TCR	NULL
signal	NULL
transduction	NULL
is	NULL
provided	NULL
by	NULL
previous	NULL
studies	NULL
.	NULL

First	NULL
,	NULL
a	NULL
rapid	NULL
but	NULL
transient	NULL
increase	NULL
in	NULL
Fyn	NULL
kinase	NULL
activity	NULL
followed	NULL
TCR	NULL
stimulation	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
overexpression	NULL
of	NULL
Fyn	NULL
in	NULL
T-cell	NULL
hybridomas	NULL
(	NULL
Ref	NULL
.	NULL

41	NULL
and	NULL
our	NULL
unpublished	NULL
data	NULL
?	NULL
)	NULL

or	NULL
in	NULL
thymocytes	NULL
of	NULL
transgenic	NULL
mice	NULL
(	NULL
17	NULL
)	NULL
resulted	NULL
in	NULL
augmented	NULL
responses	NULL
to	NULL
TCR	NULL
stimulation	NULL
.	NULL

Finally	NULL
TCR-mediated	NULL
signaling	NULL
was	NULL
defective	NULL
in	NULL
mature	NULL
thymocytes	NULL
of	NULL
Fyn-deficient	NULL
mice	NULL
,	NULL
although	NULL
the	NULL
signaling	NULL
was	NULL
unaffected	NULL
in	NULL
immature	NULL
thymocytes	NULL
and	NULL
peripheral	NULL
T-cells	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

The	NULL
conclusion	NULL
of	NULL
this	NULL
manuscript	NULL
is	NULL
consistent	NULL
with	NULL
these	NULL
observations	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
another	NULL
Src-like	NULL
kinase	NULL
Leck	NULL
that	NULL
is	NULL
primarily	NULL
expressed	NULL
in	NULL
T-cells	NULL
is	NULL
also	NULL
important	NULL
in	NULL
the	NULL
process	NULL
of	NULL
T-cell	NULL
activation	NULL
.	NULL

For	NULL
example	NULL
,	NULL
a	NULL
failure	NULL
to	NULL
express	NULL
functional	NULL
Lok	NULL
was	NULL
unable	NULL
to	NULL
activate	NULL
the	NULL
TCR-regulated	NULL
pathway	NULL
of	NULL
the	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Consistently	NULL
SRE	NULL
and	NULL
the	NULL
c-fos	NULL
promoter	NULL
were	NULL
stimulated	NULL
by	NULL
Lek	NULL
as	NULL
well	NULL
as	NULL
T-Fyn	NULL
(	NULL
Table	NULL
II	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
also	NULL
demonstrated	NULL
that	NULL
normal	NULL
Lek	NULL
,	NULL
unlike	NULL
normal	NULL
Fyn	NULL
,	NULL
was	NULL
unable	NULL
to	NULL
stimulate	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
upon	NULL
T-cell	NULL
activation	NULL
(	NULL
Table	NULL
II	NULL
,	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
Lok	NULL
and	NULL
Fyn	NULL
play	NULL
roles	NULL
in	NULL
different	NULL
phases	NULL
of	NULL
signaling	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
Fyn	NULL
functions	NULL
more	NULL
proximal	NULL
to	NULL
the	NULL
IL-2	NULL
gene	NULL
than	NULL
Lok	NULL
.	NULL

The	NULL
experimental	NULL
data	NULL
in	NULL
this	NULL
study	NULL
also	NULL
show	NULL
that	NULL
at	NULL
least	NULL
part	NULL
of	NULL
the	NULL
SH2	NULL
region	NULL
of	NULL
Fyn	NULL
is	NULL
important	NULL
in	NULL
Fyn-mediated	NULL
signaling	NULL
in	NULL
T-cells	NULL
(	NULL
Table	NULL
I	NULL
,	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Many	NULL
lines	NULL
of	NULL
evidence	NULL
show	NULL
that	NULL
SH2-containing	NULL
proteins	NULL
are	NULL
important	NULL
in	NULL
signal	NULL
transduction	NULL
(	NULL
43-45	NULL
)	NULL
.	NULL

These	NULL
proteins	NULL
include	NULL
a	NULL
phosphatidyli-nositol-specific	NULL
phospholipase	NULL
C-y	NULL
,	NULL
the	NULL
ras	NULL
GTPase-activating	NULL
protein	NULL
,	NULL
the	NULL
p85	NULL
subunit	NULL
of	NULL
phosphatidylinositol	NULL
3-kinase	NULL
,	NULL
and	NULL
Grb-2/Sem5	NULL
,	NULL
which	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
phosphorylated	NULL
at	NULL
tyrosine	NULL
residues	NULL
and/or	NULL
associated	NULL
with	NULL
receptor	NULL
protein-tyrosine	NULL
kinases	NULL
upon	NULL
ligand	NULL
stimulation	NULL
.	NULL

In	NULL
a	NULL
preliminary	NULL
study	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
CD3	NULL
{	NULL
chain	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
Fyn	NULL
protein	NULL
when	NULL
these	NULL
proteins	NULL
were	NULL
expressed	NULL
together	NULL
in	NULL
CV-1	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Others	NULL
also	NULL
showed	NULL
physical	NULL
interaction	NULL
between	NULL
Fyn	NULL
and	NULL
the	NULL
{	NULL
chain	NULL
and	NULL
demonstrated	NULL
that	NULL
the	NULL
10-amino	NULL
acid	NULL
sequence	NULL
in	NULL
the	NULL
amino-terminal	NULL
unique	NULL
domain	NULL
was	NULL
responsible	NULL
for	NULL
the	NULL
association	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
critical	NULL
role	NULL
of	NULL
the	NULL
{	NULL
chain	NULL
,	NULL
which	NULL
has	NULL
multiple	NULL
tyrosine	NULL
phosphorylation	NULL
sites	NULL
(	NULL
47	NULL
)	NULL
,	NULL
in	NULL
signal	NULL
transduction	NULL
was	NULL
clearly	NULL
demonstrated	NULL
by	NULL
analyzing	NULL
a	NULL
chimeric	NULL
protein	NULL
consisting	NULL
of	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
CD4	NULL
or	NULL
CD8	NULL
and	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
{	NULL
(	NULL
48-50	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
we	NULL
assume	NULL
that	NULL
the	NULL
SH2	NULL
sequence	NULL
of	NULL
Fyn	NULL
interacts	NULL
with	NULL
the	NULL
partly	NULL
phosphorylated	NULL
{	NULL
chain	NULL
and	NULL
that	NULL
this	NULL
interaction	NULL
increases	NULL
the	NULL
stability	NULL
of	NULL
Fyn-£	NULL
association	NULL
and	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
further	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
{	NULL
by	NULL
the	NULL
Fyn	NULL
kinase	NULL
.	NULL

The	NULL
resulting	NULL
,	NULL
heavily	NULL
phosphorylated	NULL
{	NULL
chain	NULL
would	NULL
in	NULL
turn	NULL
recruit	NULL
SH2-containing	NULL
signaling	NULL
molecules	NULL
such	NULL
as	NULL
phospholipase	NULL
C-4	NULL
,	NULL
GTPase-activating	NULL
protein	NULL
,	NULL
and	NULL
phosphatidylinositol	NULL
3-kinase	NULL
,	NULL
as	NULL
insulin	NULL
receptor-associated	NULL
p185	NULL
,	NULL
which	NULL
becomes	NULL
phospho-	NULL
Regulation	NULL
of	NULL
T-cell	NULL
Signaling	NULL
by	NULL
Protein-tyrosine	NULL
Kinases	NULL
rylated	NULL
at	NULL
multiple	NULL
tyrosine	NULL
residues	NULL
by	NULL
the	NULL
insulin	NULL
receptor	NULL
upon	NULL
insulin	NULL
stimulation	NULL
,	NULL
interacts	NULL
with	NULL
phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
51	NULL
)	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
ZAP-70	NULL
protein-tyrosine	NULL
kinase	NULL
,	NULL
which	NULL
was	NULL
identified	NULL
as	NULL
{	NULL
-associated	NULL
kinase	NULL
,	NULL
contains	NULL
two	NULL
SHZ2	NULL
motives	NULL
and	NULL
is	NULL
rapidly	NULL
tyrosine-phosphorylated	NULL
after	NULL
stimulation	NULL
of	NULL
T-cells	NULL
(	NULL
52	NULL
,	NULL
53	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
present	NULL
data	NULL
suggest	NULL
that	NULL
at	NULL
least	NULL
some	NULL
fraction	NULL
of	NULL
Csk	NULL
is	NULL
associated	NULL
with	NULL
TCR	NULL
.	NULL

Csk	NULL
might	NULL
be	NULL
recruited	NULL
by	NULL
phosphorylated	NULL
{	NULL
to	NULL
complete	NULL
negative	NULL
regulation	NULL
of	NULL
Fyn	NULL
and/or	NULL
Lock	NULL
kinases	NULL
,	NULL
resulting	NULL
in	NULL
down-regulation	NULL
of	NULL
signaling	NULL
.	NULL

The	NULL
kinase	NULL
activity	NULL
of	NULL
the	NULL
Src	NULL
family	NULL
is	NULL
regulated	NULL
by	NULL
phosphorylation	NULL
and	NULL
dephosphorylation	NULL
of	NULL
a	NULL
tyrosine	NULL
residue	NULL
that	NULL
corresponds	NULL
to	NULL
Tyr-527	NULL
of	NULL
c-Sre	NULL
and	NULL
is	NULL
conserved	NULL
among	NULL
the	NULL
family	NULL
members	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
this	NULL
regulatory	NULL
tyrosine	NULL
is	NULL
catalyzed	NULL
by	NULL
a	NULL
cytoplasmic	NULL
protein-tyrosine	NULL
kinase	NULL
Csk	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
Sre	NULL
kinase	NULL
activity	NULL
by	NULL
Csk	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
yeast	NULL
(	NULL
10	NULL
,	NULL
12	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
kinase	NULL
activity	NULL
of	NULL
Fyn	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
down-regulated	NULL
in	NULL
vitro	NULL
by	NULL
Csk	NULL
(	NULL
10	NULL
)	NULL
,	NULL
regulation	NULL
of	NULL
Fyn	NULL
kinase	NULL
by	NULL
Csk	NULL
in	NULL
intact	NULL
cells	NULL
has	NULL
not	NULL
been	NULL
demonstrated	NULL
.	NULL

Our	NULL
present	NULL
data	NULL
clearly	NULL
show	NULL
that	NULL
Csk	NULL
suppresses	NULL
activities	NULL
of	NULL
Fyn	NULL
and	NULL
Lek	NULL
to	NULL
stimulate	NULL
the	NULL
c-fos	NULL
and	NULL
IL-2	NULL
promoters	NULL
in	NULL
T-cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
Csk	NULL
is	NULL
involved	NULL
in	NULL
TCR-mediated	NULL
signaling	NULL
.	NULL

Furthermore	NULL
we	NULL
demonstrated	NULL
co-immunoprecipitation	NULL
of	NULL
(	NULL
sk	NULL
and	NULL
Fyn	NULL
from	NULL
the	NULL
lysates	NULL
of	NULL
Fyn-overexpressed	NULL
cells	NULL
by	NULL
means	NULL
of	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
efficiency	NULL
of	NULL
co-immunoprecipitation	NULL
was	NULL
low	NULL
,	NULL
and	NULL
preliminary	NULL
data	NULL
indicated	NULL
that	NULL
no	NULL
more	NULL
than	NULL
1	NULL
%	NULL
of	NULL
Fyn	NULL
was	NULL
physically	NULL
associated	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
of	NULL
this	NULL
interaction	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
,	NULL
however	NULL
,	NULL
that	NULL
no	NULL
association	NULL
of	NULL
Csk	NULL
with	NULL
Sre	NULL
was	NULL
observed	NULL
in	NULL
fibroblasts	NULL
(	NULL
54	NULL
)	NULL
.	NULL

Nevertheless	NULL
recent	NULL
studies	NULL
in	NULL
this	NULL
laboratory	NULL
suggested	NULL
physical	NULL
interaction	NULL
of	NULL
Lyn	NULL
and	NULL
Fyn	NULL
with	NULL
Csk	NULL
when	NULL
both	NULL
kinases	NULL
were	NULL
overexpressed	NULL
in	NULL
CV-1	NULL
monkey	NULL
kidney	NULL
cells	NULL
.	NULL
``	NULL

Further	NULL
studies	NULL
are	NULL
needed	NULL
to	NULL
explain	NULL
the	NULL
apparent	NULL
discrepancy	NULL
.	NULL

Both	NULL
Fyn	NULL
and	NULL
Lek	NULL
are	NULL
associated	NULL
with	NULL
the	NULL
antigen-major	NULL
histocompatibility	NULL
complex	NULL
receptor	NULL
system	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Moreover	NULL
Csk	NULL
is	NULL
expressed	NULL
ubiquitously	NULL
but	NULL
is	NULL
expressed	NULL
at	NULL
highest	NULL
levels	NULL
in	NULL
certain	NULL
tissues	NULL
that	NULL
include	NULL
thymus	NULL
(	NULL
10	NULL
)	NULL
and	NULL
has	NULL
been	NULL
isolated	NULL
from	NULL
the	NULL
cellular	NULL
membrane	NULL
fraction	NULL
(	NULL
9	NULL
)	NULL
.	NULL

These	NULL
data	NULL
together	NULL
suggest	NULL
that	NULL
Csk	NULL
functions	NULL
in	NULL
the	NULL
TCR-CD3-mediated	NULL
signaling	NULL
pathway	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Y.	NULL
Yamanashi	NULL
and	NULL
T.	NULL
Katagiri	NULL
for	NULL
fruitful	NULL
discussions	NULL
,	NULL
T.	NULL
Hunter	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
S.	NULL
Ishii	NULL
,	NULL
K.	NULL
Maruyama	NULL
,	NULL
T.	NULL
Shimotohno	NULL
,	NULL
and	NULL
K.	NULL
Kaibuchi	NULL
for	NULL
plasmids	NULL
,	NULL
and	NULL
M.	NULL
Kaji-Ide	NULL
and	NULL
K.	NULL
Kawana	NULL
for	NULL
assistance	NULL
in	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1.	NULL
Cooper	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
in	NULL
Peptides	NULL
and	NULL
Protein	NULL
Phosphorylation	NULL
(	NULL
Kemp	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
and	NULL
Alewood	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

85-113	NULL
,	NULL
CRC	NULL
Press	NULL
,	NULL
Inc.	NULL
,	NULL
Boca	NULL
Raton	NULL
,	NULL
FL	NULL
2	NULL
.	NULL

Semba	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Toyoshima	NULL
,	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
Genes	NULL
and	NULL
Cancer	NULL
(	NULL
Sikora	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Carney	NULL
,	NULL
D.	NULL
,	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

73-83	NULL
,	NULL
Wiley	NULL
,	NULL
Chichester	NULL
,	NULL
UK	NULL
3	NULL
.	NULL

Veillette	NULL
,	NULL
A.	NULL
,	NULL
Bookman	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Horak	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
and	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
301-308	NULL
4	NULL
.	NULL

Barber	NULL
,	NULL
E.	NULL
K.	NULL
,	NULL
Dasgupta	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Schlossman	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Trvillyan	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Rudd	NULL
,	NULL
C.	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
3277-3281	NULL
5	NULL
,	NULL
Veillette	NULL
,	NULL
A.	NULL
,	NULL
Bookman	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Horak	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Sameison	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
and	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
388	NULL
,	NULL
257-259	NULL
6	NULL
.	NULL

Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Phillips	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Luong	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
and	NULL
Klausner	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
4358-4962	NULL
7	NULL
.	NULL

Yamanashi	NULL
,	NULL
Y.	NULL
,	NULL
Kakiuchi	NULL
,	NULL
T.	NULL
,	NULL
Mizuguchi	NULL
,	NULL
J.	NULL
,	NULL
Yamamoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Toyoshima	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
251	NULL
,	NULL
192-194	NULL
8	NULL
.	NULL

Hatakeyama	NULL
,	NULL
M.	NULL
,	NULL
Kono	NULL
,	NULL
T.	NULL
,	NULL
Kobayashi	NULL
,	NULL
N.	NULL
,	NULL
Kawahara	NULL
,	NULL
A.	NULL
,	NULL
Levin	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Perlmutter	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
252	NULL
,	NULL
1523-1528	NULL
9	NULL
.	NULL

Okada	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Nakagawa	NULL
,	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
20886-20893	NULL
10	NULL
.	NULL

Okada	NULL
,	NULL
M.	NULL
,	NULL
Nada	NULL
,	NULL
S.	NULL
,	NULL
Yamanashi	NULL
,	NULL
Y.	NULL
,	NULL
Yamamoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Nakagawa	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

206	NULL
,	NULL
24249-24252	NULL
11	NULL
.	NULL

Sabe	NULL
,	NULL
H.	NULL
,	NULL
Okada	NULL
,	NULL
M.	NULL
,	NULL
Nakegawa	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Hanafusa	NULL
,	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4706-4713	NULL
12	NULL
.	NULL

Superti-Furga	NULL
,	NULL
G.	NULL
,	NULL
Fumagili	NULL
,	NULL
S.	NULL
,	NULL
Koeg	NULL
!	NULL

,	NULL
M.	NULL
,	NULL
Courtneidge	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
and	NULL
Dractta	NULL
,	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
2625-2634	NULL
°	NULL
Y.	NULL
Yamanashi	NULL
,	NULL
N.	NULL
Okada	NULL
,	NULL
and	NULL
T.	NULL
Yamamoto	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

Regulation	NULL
of	NULL
T-cell	NULL
Signaling	NULL
by	NULL
Protein-tyrosine	NULL
Kinases	NULL
Yamanashi	NULL
,	NULL
Y.	NULL
,	NULL
Mori	NULL
,	NULL
S.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
Inoue	NULL
,	NULL
K.	NULL
,	NULL
Yamamoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Toyoshima	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
6538-6542	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
355-361	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
and	NULL
Klausner	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
24913-24916	NULL
June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Flecher	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Schieven	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Siegel	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Phillips	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
and	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
71722-1726	NULL
Cooke	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Abraham	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Forbush	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
and	NULL
Perlmutter	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
65	NULL
,	NULL
281-291	NULL
Stein	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Lee	NULL
,	NULL
H.-M.	NULL
,	NULL
Rich	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Soriano	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
741-750	NULL
Appleby	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Gross	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Cooke	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Levin	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Xian	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
Perimut-ter	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
751-763	NULL
Takebe	NULL
,	NULL
Y.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Fujisawa	NULL
,	NULL
J.-L.	NULL
,	NULL
Hoy	NULL
,	NULL
P.	NULL
,	NULL
Yokota	NULL
,	NULL
K.	NULL
,	NULL
Arai	NULL
,	NULL
K.~I	NULL
.	NULL

,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
466-472	NULL
Semba	NULL
,	NULL
K.	NULL
,	NULL
Kawai	NULL
,	NULL
S.	NULL
,	NULL
Matsuzawa	NULL
,	NULL
Y.	NULL
,	NULL
Yamanashi	NULL
,	NULL
Y.	NULL
,	NULL
Nishizawa	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Toyoshima	NULL
,	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
3095-3104	NULL
Cooke	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
and	NULL
Perlmutter	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

1	NULL
,	NULL
66-74	NULL
Mullis	NULL
,	NULL
K.	NULL
B.	NULL
,	NULL
and	NULL
Faloona	NULL
,	NULL
F.	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

155	NULL
,	NULL
335-350	NULL
Takeya	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Hanafusa	NULL
,	NULL
H.	NULL
(	NULL
1983	NULL
)	NULL
Cell	NULL
82	NULL
,	NULL
881-890	NULL
Ohta	NULL
,	NULL
M.	NULL
,	NULL
Morita	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Shimotohno	NULL
,	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

81	NULL
,	NULL
440-444	NULL
Nada	NULL
,	NULL
S.	NULL
,	NULL
Okada	NULL
,	NULL
M.	NULL
,	NULL
MacAuley	NULL
,	NULL
A.	NULL
,	NULL
Cooper	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Nakagawa	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
8351	NULL
,	NULL
69-72	NULL
Kunkel	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

82	NULL
,	NULL
488-492	NULL
Kaibuchi	NULL
,	NULL
K.	NULL
,	NULL
Fukumoto	NULL
,	NULL
Y.	NULL
,	NULL
Oku	NULL
,	NULL
N.	NULL
,	NULL
Hori	NULL
,	NULL
Y.	NULL
,	NULL
Yamamoto	NULL
,	NULL
T.	NULL
,	NULL
Toyoshima	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Takai	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
20855-20858	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Shibuya	NULL
,	NULL
H.	NULL
,	NULL
Ohashi	NULL
,	NULL
T.	NULL
,	NULL
Yamanishi	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
401-407	NULL
Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
Uchiumi	NULL
,	NULL
F.	NULL
,	NULL
Semba	NULL
,	NULL
K.	NULL
,	NULL
Yamanashi	NULL
,	NULL
Y.	NULL
,	NULL
Fujisawa	NULL
,	NULL
J.-L.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Inoue	NULL
,	NULL
K.	NULL
,	NULL
Toyoshima	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
3784-3795	NULL
Katagiri	NULL
,	NULL
T.	NULL
,	NULL
Urakawa	NULL
,	NULL
K.	NULL
,	NULL
Semba	NULL
,	NULL
K.	NULL
,	NULL
Yamanashi	NULL
,	NULL
Y.	NULL
,	NULL
Takahashi	NULL
,	NULL
T.	NULL
,	NULL
Toyoshima	NULL
,	NULL
K.	NULL
,	NULL
Yamamoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kano	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
10064-10068	NULL
Okada	NULL
,	NULL
M.	NULL
,	NULL
Nada	NULL
,	NULL
S.	NULL
,	NULL
Yamanashi	NULL
,	NULL
Y.	NULL
,	NULL
Yamamoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Nakagawa	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
,	NULL
Chem	NULL
.	NULL

266	NULL
,	NULL
24249-24252	NULL
34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

27419	NULL
Manger	NULL
,	NULL
B.	NULL
,	NULL
Weiss	NULL
,	NULL
A.	NULL
,	NULL
Weyand	NULL
,	NULL
C.	NULL
,	NULL
Goronzy	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Stobo	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1985	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

135	NULL
,	NULL
3669-3673	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Sassone-Corsi	NULL
,	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
513-514	NULL
Caron	NULL
,	NULL
L.	NULL
,	NULL
Abraham	NULL
,	NULL
N.	NULL
,	NULL
Pawson	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Veillette	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
2720-2729	NULL
O'Shea	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Ashwell	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Bailey	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
and	NULL
Klausner	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
1741-1745	NULL
Luo	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Sefton	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4724-4732	NULL
Ullrich	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Schlessinger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
203-212	NULL
Teygankov	NULL
,	NULL
A.	NULL
Y.	NULL
,	NULL
Broker	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
Fargnoli	NULL
,	NULL
J.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
18259-18262	NULL
Davidson	NULL
,	NULL
D.	NULL
,	NULL
Chow	NULL
,	NULL
L.	NULL
M.	NULL
L.	NULL
,	NULL
Fournel	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Veillette	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
1483-1492	NULL
Straus	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
585-593	NULL
Koch	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Anderson	NULL
,	NULL
D.	NULL
,	NULL
Moran	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Ellis	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Pawson	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
252	NULL
,	NULL
668-674	NULL
Cantley	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Auger	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
Carpenter	NULL
,	NULL
C.	NULL
,	NULL
Duckworth	NULL
,	NULL
B.	NULL
,	NULL
Graziani	NULL
,	NULL
A.	NULL
,	NULL
Kapel-ler	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Soltoff	NULL
,	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
281-302	NULL
Pawson	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Gish	NULL
,	NULL
G.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
71	NULL
,	NULL
359-362	NULL
Gauen	NULL
,	NULL
L.	NULL
K.	NULL
T.	NULL
,	NULL
Kong	NULL
,	NULL
A.-T.	NULL
T.	NULL
,	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
and	NULL
Shaw	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
5438-5446	NULL
Koyasu	NULL
,	NULL
S.	NULL
,	NULL
McConkey	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Clayton	NULL
,	NULL
L.	NULL
K.	NULL
,	NULL
Abraham	NULL
,	NULL
S.	NULL
,	NULL
Yandava	NULL
,	NULL
B.	NULL
,	NULL
Kata-gini	NULL
,	NULL
T.	NULL
,	NULL
Yamamoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Reinhertz	NULL
,	NULL
E.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
3375-3381	NULL
Irving	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
891-901	NULL
Romeo	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Seed	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
1037-1046	NULL
Wegener	NULL
,	NULL
A.-M.	NULL
K.	NULL
,	NULL
Letourneur	NULL
,	NULL
F.	NULL
,	NULL
Hoeveler	NULL
,	NULL
A.	NULL
,	NULL
Brocker	NULL
,	NULL
T.	NULL
,	NULL
Lucton	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Malissen	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
83-95	NULL
Sun	NULL
,	NULL
X.	NULL
J.	NULL
,	NULL
Rothenberg	NULL
,	NULL
P.	NULL
,	NULL
Kahn	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Backer	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Araki	NULL
,	NULL
E.	NULL
,	NULL
Wilden	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Cabhill	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Goldstein	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
and	NULL
White	NULL
,	NULL
M.	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
852	NULL
,	NULL
73-77	NULL
Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Irving	NULL
,	NULL
B.	NULL
,	NULL
Fraser	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
9166-9170	NULL
Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Iwashima	NULL
,	NULL
M.	NULL
,	NULL
Turck	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
71	NULL
,	NULL
649-662	NULL
Sabe	NULL
,	NULL
H.	NULL
,	NULL
Knudsen	NULL
,	NULL
B.	NULL
,	NULL
Nada	NULL
,	NULL
S.	NULL
,	NULL
Okada	NULL
,	NULL
M.	NULL
,	NULL
Nakagawa	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Hanafusa	NULL
,	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
2190-2194	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Shibuya	NULL
,	NULL
H.	NULL
,	NULL
Harada	NULL
,	NULL
H.	NULL
,	NULL
Hatakeyama	NULL
,	NULL
M.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Inoue	NULL
,	NULL
J.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
348-350	NULL

